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Risk assessment is a process often divided into the following steps: a) hazard identification,
b) dose-response assessment, c) exposure assessment, and d) risk characterization. Regulatory
toxicity studies usually are aimed at providing data for the first two steps. Human case reports,
environmental research, and in vitro studies may also be used to identify or to further characterize
a toxic hazard. In this report the strengths and limitations of in vitro techniques are discussed in
light of their usefulness to identify neurotoxic hazards, as well as for the subsequent
dose-response assessment. Because of the complexity of the nervous system, multiple
functions of individual cells, and our limited knowledge of biochemical processes involved in
neurotoxicity, it is not known how well any in vitro system would recapitulate the in vivo system.
Thus, it would be difficult to design an in vitro test battery to replace in vivo test systems. In vitro
systems are well suited to the study of biological processes in a more isolated context and have
been most successfully used to elucidate mechanisms of toxicity, identify target cells of
neurotoxicity, and delineate the development and intricate cellular changes induced by
neurotoxicants. Both biochemical and morphological end points can be used, but many of the end
points used can be altered by pharmacological actions as well as toxicity. Therefore, for many of
these end points it is difficult or impossible to set a criterion that allows one to differentiate
between a pharmacological and a neurotoxic effect. For the process of risk assessment such a
discrimination is central. Therefore, end points used to determine potential neurotoxicity of a
compound have to be carefully selected and evaluated with respect to their potential to discrimi-
nate between an adverse neurotoxic effect and a pharmacologic effect. It is obvious that for in
vitro neurotoxicity studies the primary end points that can be used are those affected through
specific mechanisms of neurotoxicity. For example, in vitro systems may be useful for certain
structurally defined compounds and mechanisms of toxicity, such as organophosphorus
compounds and delayed neuropathy, for which target cells and the biochemical processes
involved in the neurotoxicity are well known. For other compounds and the different types of
neurotoxicity, a mechanism of toxicity needs to be identified first. Once identified, by either in
vivo or in vitro methods, a system can be developed to detect and to evaluate predictive ability for
the type of in vivo neurotoxicity produced. Therefore, in vitro tests have their greatest potential in
providing information on basic mechanistic processes in order to refine specific experimental
questions to be addressed in the whole animal. Environ Health Perspect 106(Suppi 1):131-158
(1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-1/131-158harry/abstract.html
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Neurotoxicology is the study of the adverse
effects of chemical, biological, and certain
physical agents on the nervous system
and/or behavior during development and
in maturity. The topic ofrisk assessment in
noncancer end points including neuro-
toxicology has received much attention and
has led to the development of a systematic
scientific and administrative framework to
assess risk associated with exposure to
chemical and physical agents (1). Risk
assessment is defined as "the characteriza-
tion of the potential adverse health effects
of human exposures to environmental haz-
ards" (2). The process of risk assessment is
often divided into the following steps:
a) hazard identification, b) dose-response
assessment, c) exposure assessment, and
d) risk characterization. The initial step in
the risk assessment process is the identifica-
tion ofhazard. Hazard is defined as the like-
lihood that injury will occur in a given
situation or setting. Human case reports,
experimental laboratory animal studies,
environmental research, and in vitro studies
can all be used to identify toxic hazards.
These studies can also be used to character-
ize the dose-response relationship between
chemical exposure and toxicity. This infor-
mation is critical in the identification of
risk, which defines the likelihood of an
adverse effect occurring under actual expo-
sure conditions. Another important step in
the risk assessment process is the determina-
tion of a quantitative estimate of risk. These
estimates are derived from the extrapolation
of experimental dose-response models
obtained from animal or human studies to
predict the type and estimate the extent of
health effects in humans resulting from
anticipated human exposure. Throughout
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these steps, research needs are identified
from the riskassessment process (3).
Principles oftheNervous System-
Potential SitesofNeurotoxicAttack
The nervous system comprises two compo-
nents: the central nervous system (CNS),
which is composed of the brain and the
spinal cord, and the peripheral nervous sys-
tem (PNS), which comprises the ganglia
and the peripheral nerves lying outside of
the brain and spinal cord inclusive ofthe
autonomic nervous system. Two general
types ofcells are predominant in the ner-
vous system: neurons and neuroglial cells
(oligodendrocytes, astrocytes, microglia; and
in the PNS, the Schwann cells). Neurons
are similar to all other cells ofthe body in
general structure, but they have additional
anatomical features ofaxons and dendrites
that allow conduction ofnerve impulses for
communication with other neural cells and
between neuronal populations. The den-
drites are elongated processes that emanate
from the cell bodyand increase the neuronal
surface area available to receive input from
other sources. The surface area ofthe axonal
process can be tens to thousands times
greater than the cell body diameter and is
specialized for the conduction of nerve
impulses away from the cell body toward
the terminal synapse and other cells (neu-
rons, muscle cells, or glandular cells). The
neuronal cell body synthesizes the necessary
components for maintaining structural
components ofthe membrane (e.g., proteins
and lipids) and general cell functioning.
Many axons are surrounded by layers of
membrane from the cell processes ofglia
cells (the myelin sheath). Oligodendrocytes
in the CNS and Schwann cells in the PNS
form this myelin sheath. The myelin exten-
sion from any one cell covers only a short
length ofthe axon, requiring a continuous
series ofglial cells to ensheath an entire
axon. The presence ofthe myelin lamella
allows for the acceleration of the nerve
impulse by permitting salutatory conduc-
tion between the myelin sheath ofeach glia
cell identified as the node ofRanvier. At
each node the axon is nonmyelinated yet
enveloped by teloglial cells. Although
nonmyelinated axons are devoid ofmyelin
lamella, theyareensheathed byplasmolemma
ofthe similar cells.
Neurons are highly specialized cells and
are responsible for the reception, integration,
transmission, and storage ofinformation.
Afferent neuronal pathways carry informa-
tion into the nervous system for processing;
efferent pathways carry commands to the
periphery. In addition, there are interneu-
rons that process local information and
transfer data within the nervous system.
Within the CNS, neurons are segregated
into functionally related nuclei that form
interconnecting bundles ofaxonal fibers.
Higher organizational levels consisting of
several functionally related neurons are fre-
quently called systems, e.g., motor, visual,
associative, and neuroendocrine systems.
The CNS consists ofa number ofsystems
responsible for the coordination of receiv-
ing and processing information from the
environment, maintaining the balance of
all other organ systems, and responding to
changes in the environment.
The in vivo reactions of neurons to
injury vary dramatically. Degeneration can
be induced by a direct action on the peri-
karyon or loss ofsynaptic target site influ-
ences and deprivation oftrophic factors. A
number ofchemicals appear to have distinct
cellular specificity for neuronal populations.
Although specificity can exist and the pat-
tern ofdegeneration has been used in diag-
nostic neuropathology, degeneration ofany
particular neuronal type cannot necessarily
identify the damaging agent. Often this pat-
tern reflects the severity and duration ofthe
injury and the acuteness or chronic nature
ofexposure. The degenerative process ofthe
nerve cell can be either relatively quick or a
slow, prolonged process, depending on the
underlying mechanism.
Unlike neurons, glial cells have no true
synaptic contacts; however, receptors for
several neurotransmitters are present and
functional on various glial cells. Cell-cell
contacts exist between the glial cells and
neurons that may regulate both neuronal
and glial differentiation and are critical for
the glial-guided migration ofneurons dur-
ing development. Glial cells have a dynamic
nature and provide critical processes neces-
sary to maintain normal functioning ofthe
nervous system (e.g., regulation oflocal pH
and ionic balances, and tropic support for
neurite extension in the form ofgrowth fac-
tors and cell adhesion factors). They can
also be the target for a toxic response. For
either the oligodendrocyte or the Schwann
cell, the myelin membrane is vulnerable to
numerous substances, toxic agents, and
demyelinating autoimmune diseases such as
multiple sclerosis and Guillian-Barre syn-
drome that specifically target and break
down the myelin sheath. After injury to the
nervous system, the astrocyte and the
microglia both display profound responses.
The astrocyte responds byproliferation or a
morphological change characterized by
cellular hypertrophy. This process of reac-
tive gliosis has been proposed as an early
marker ofdamage to the nervous system
and can be detected morphologically or
quantified by measurements of an astro-
cyte-specific protein, glial fibrillary acidic
protein (GFAP). The sequence of the
response can be rapid and transient or pro-
gressive and sustained over an extended
period oftime. The microglial cell assumes
an immunologic role and is seen in the nor-
mal brain in a resting state; however, with
injury it can become mobile and assume
macrophage-like characteristics. In the
PNS, thisphagocytic role isprovidedby the
resident macrophage as well as by the infil-
trating peripheral macrophages. In a toxi-
cant-induced response of the nervous
system, each cell type maycontribute to the
overall manifestation ofneurotoxicity not
only individually but based upon complex
cell-cell interactions altered or initiated
during theinjury response.
Roleofin Vitrt Systems in
DeterminingNeurotoxicity
In the field ofneurobiology, in vitro cell
culture techniques have been successfully
developed and employed to address spe-
cific questions ofcell biology and nervous
system functioning and provide a means to
systematically study complex nervous sys-
tems (4-8). Such systems have two major
and critical functions. First, they teach
neuroscientists and neurotoxicologists the
complexity of cellular functions of CNS
elements. Second, they provide a conve-
nient experimental tool for testing possible
functions or postulates in vivo that other-
wise might not be conducted (9,10). Cells
harvested directly from the organism, dis-
sociated into single cells before seeding into
the culture vessel, and maintained in vitro
for periods exceeding 24 hr are defined as
primary cell cultures. If tissue fragments
are maintained in vitro, the culture is
referred to as an explant culture. Cell lines
are cultures that have been serially trans-
planted or subcultured through a number
ofgenerations and can be propagated for
an extended period of time. In neuro-
biology, in vitromethods are not ordinarily
considered as alternatives to in vivo pro-
cedures. Instead, in vitro methods are
selected to address specific hypotheses.
Studies with tissues, cells, or cell fragments
mayprovide the most appropriate approach
and in many cases cannot be conducted in
live animals. Therefore, in vitro models are
used in an attempt to study biological
processes in a more isolated context or in
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the direct investigation ofspecific biologi-
cal processes. It is generally recognized
that in vitro systems often provide only
partial answers to more complex problems;
therefore, they can supplement, but rarely
replace, investigations with whole animals.
For many questions in biology and medi-
cine, in vitro techniques may not be
suitable. For example, in vitro techniques
offer little information about a chemical
effect on sensory or cognitive function. If
one is interested in investigating the effects
on the central processing of a message
received by receptor cells, storage of this
information in short- and long-term
memory, or behavioral and somatic res-
ponses resulting from some of the sensory
perception, assessment of the whole
animal is essential.
Various types of in vitro approaches
produce data for evaluating potential and
known neurotoxic substances, including
primary cell cultures, cell lines, and cloned
cells. Although such procedures are impor-
tant in studying the mechanism ofaction
oftoxic agents, their use in hazard identifi-
cation in human health risk assessment has
not been widely accepted. For example, the
proposed guidelines for neurotoxicity risk
assessment published by the the U.S.
Environmental Protection Agency (U.S.
EPA) (11) raise concerns about the ability
of in vitro techniques to predict the neuro-
toxicity ofvarious agents found in humans
and animal models. This validation step
requires considerations in study design,
including defined end points of toxicity
and an understanding ofhow a test chemi-
cal would be handled in vitro as compared
to the intact organism. The neurotoxicity
risk assessment guidelines propose that
demonstrated neurotoxicity in vitro in the
absence of in vivo data is suggestive, but
inadequate evidence of a neurotoxic effect.
Thus, the in vitro data is used often to
enhance the reliability ofin vivodata.
Use of in VitroTechniques
for Evaluating Neurotoxicity
Rationale
The rationale for the use of in vitro proce-
dures to assess neurotoxicants is based upon
a clear understanding of mechanistic
processes underlying normal nervous system
functioning and some forms ofdysfunction.
When applied to chemical-induced pertur-
bations ofthe nervous system, knowledge of
biological mechanisms has led to the exami-
nation ofmore sophisticated and subtle bio-
logically based expressions ofneurotoxicity.
This advance has been seen in all levels of
examination, from the integrative function-
ing ofthe nervous system as manifest by
behavioral alterations, to morphological and
biochemical alterations in the intact animal,
to the molecular mechanisms associated
with injury response ordevelopment, and to
the intricate cellular changes examined by
in vitrotechniques.
Although the assessment of neurotoxic
end points in the whole animal are pre-
sumed to be causally related to those initi-
ated at the cellular level, in many cases the
cascade ofeffects is not well understood.
Chemicals rarely ifever affect all neurons
indiscriminately but instead induce selec-
tive damage. Cellular toxicity depends on
the specific sensitivity ofthe cell as well as
on the extracellular concentration of the
test compound. The effects seen may not
be due to the primary toxicant adminis-
tered but rather the result ofbioactivation
with subsequent response to a metabolite.
In addition, toxic responses of neurons in
vivo may be the result oftoxicity of non-
neuronal or nonneural cells, e.g., glial cells,
endothelial cells. Observed responses may
even be due to a systemic biological process
activated by exposure such as hepatic
encephalopathy or may be observed only
with maturation or aging of the system.
These features create a major problem in
selecting an in vitro system that will model
the nervous system target site or process for
any particular chemical. With the use ofin
vitro systems, it must be kept in mind that
no existing in vitro system will be able to
measure all chemically induced effects.
This limitation is due partly to the lack of
all possible target sites and the synergistic
interaction between the cell types. In addi-
tion, the limited culture life may not allow
for the appearance ofdelayed responses or
allow for discrimination between transient
and persistent effects.
Many chemicals are introduced for
industrial use with limited knowledge of
how they might affect a biological organ-
ism. Alteration in structure ofindustrial or
agriculture chemicals may appear trivial
from a chemical perspective, e.g., addition
or substitution ofa methyl group, but that
same change may have dramatic conse-
quences with regard to activity in biologi-
cal systems. In general, safety testing is
designed to reduce unnecessary exposure of
human and other animal populations.
Thus, the optimal system for hazard identi-
fication would be the one most closely
resembling the phenotype of concern in
biochemical, physiological, molecular, and
other cellular and organ processes. Dose-
response data obtained from in vitro
studies must be used with caution because
ofsignificant differences in the pharmaco-
kinetic behavior of chemicals observed in
vivo and in vitro. In addition, effects
observed in vitro are not necessarily pre-
dictive ofwhether an adverse effect will
occur following exposure in vivo. How-
ever, mechanism(s) of neurotoxicity
identified using in vitro studies may con-
tribute to determining whether an effect
observed in vitro may also result in an
adverse effect in animals or humans
following chemical exposure.
Advanuges andDisadvantages
The use of in vitro systems for toxicity
testing has been discussed in numerous
review articles (12-18). In each of these
reviews, a number ofvarious advantages
and disadvantages have been identified
(Table 1).
Access to the Cellular Environment.
The physicochemical environment ofcells
is easily manipulated in vitro. Substances
can be added or withdrawn from the cul-
ture medium, allowing precise temporal
analysis of the sequence of events. The
concentration of the test chemical can be
controlled in terms of the amount being
delivered to the entire cell population or to
an individual target cell; however, this con-
centration must be consistent with the in
vivo level ofexposure to be meaningful. In
Table 1. General advantages and limitations of in vitro
studies in neurotoxicology.
Access to the cell environment
Advantages
Abilityto expose cells directly to a chemical
Abilityto manipulate environmental conditions to
augment, block, or modulate cell response
Evaluation of intrinsic cell response ofcell to
chemical













Lack of in vivochemical disposition factors
Lack of in vivochemical metabolism
Lack of in vivofiltering mechanisms
Blood-brain and blood-nerve barriers
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addition, the compound should be pre-
sented to the cells in a physiological formu-
lation. Techniques exist that allow the
direct injection of a substance into a cell
and examination of the resulting cellular
responses. However, the use ofsuch tech-
niques is limited to specific experimental
questions, given the nonphysiological
administration, the possible localized dis-
tribution of the chemical, and the injury
induced bythe injection alone.
Physicochemical properties ofchemicals,
such as solubility, volatility, pH, binding
to components of the culture medium
including protein binding, and osmolarity,
must be considered prior to use in culture
systems. It is difficult to evaluate in vitro
chemicals that are either insoluble in aque-
ous systems or at neutral pH, thus forming
insoluble particulate or precipitate over
time. To expose cells to such insoluble
compounds, additives like dimethyl sulfox-
ide (DMSO), Tween-80, or ethanol, are
often added to the culture medium and
could distort the toxicological characteris-
tics. Some investigators have attempted to
overcome these problems by solublizing
the compounds using physiological carriers
such as albumin, lipoproteins, or a specific
carrier. Many other chemicals may be
volatile and evaporate quickly. Such phys-
iochemical properties present major prob-
lems in terms ofobtaining adequate and
constant concentrations ofthe compound
ofinterest. The chemical nature ofthe sub-
stance administered must be considered.
Alterations in the osmolarity or pH shifts
in the culture medium can occur that are
toxic to the cells or could stimulate the pre-
cipitation of nutrients from the culture
media. The addition ofa test chemical to
the nutrient fluid could result in a direct
reaction between the test compound and a
component of the culture medium (e.g.,
protein denaturation, precipitation), possi-
bly affecting the availability ofthe toxicant
or essential nutrients, and modifying sig-
nals to the cultured cells. Any protein-
binding properties of test chemicals could
directly alter the microenvironment ofcul-
tured cells in a fashion that may not occur
in vivo.
ChemkalDisposition andMetabolism
Toxicokinetics consists of absorption,
distribution, metabolism, and excretion of
chemicals and their metabolites following
exposure. The dose needed to induce toxic
effects depends on these pharmacokinetic
parameters. For example, the route by
which a chemical enters the body can sub-
stantially alter the quantity absorbed and
consequently modify the dose required to
cause toxicity. Metabolism at the site of
absorption (e.g., gastrointestinal tract, skin,
lung) may determine the quantity ofthe
compound reaching the circulatory system
and the type and concentration ofpossible
toxic metabolites. The absorbed compound
may be distributed throughout the body by
the circulatory system. Within the organ-
ism, the compound may be bioactivated
and/or detoxified before it is released back
into the circulation. Such metabolism and
biotransformation offoreign compounds in
the body can be affected by various enzy-
matic processes. The specificity and velocity
ofeach are strongly species dependent (19).
The rate ofremoval ofa compound depends
not only on metabolism but also on the
excretion rate; large species differences in
steady-state levels can occur due to differ-
ences in elimination rate. Differences in
drug metabolism and excretion are widely
considered to be an important reason for the
large species differences observed in both
dose and type oftoxic response following
drug or chemical exposure.
In culture, a test compound either
remains unaltered or is relatively slowly
modified, and one can examine the intrinsic
toxicity of a substance to a cell in the
absence ofany metabolites. Many com-
pounds require metabolic activation; others
are detoxified by metabolism. For example,
methyl n-butyl ketone is metabolized to the
active compounds 2,5-hexanedione and
2,5-hexanediol. Xenobiotic inactivation sys-
tems are expressed in neural tissue, predom-
inantly in nonneuronal cells (20). In
addition, blood enzymes such as organo-
phosphate hydrolyzing plasma esterase can
be introduced via serum supplementation
ofgrowth media. The combined effect of
these modifications can lead to unantici-
pated reductions in the actual concentra-
tion of the test agent. It is critical to
understand the in vivo metabolism, distrib-
ution, and effects ofpotential metabolites
in order to interpret data obtained from
both in vivo studies and tissue culture sys-
tems. If the neurotoxic potential of a
chemical in vivo is dependent upon meta-
bolic parameters such as biotransforma-
tion, lipid-aqueous partitioning, and
distribution, then the expression oftoxicity
in a culture system may be meaningless
when related to whole-animal studies.
METABOLIC ACTIVATION SYSTEM. For
certain classes ofcompounds (e.g., cyclo-
phosphamide activated by cytochrome
P450-dependent monooxygenase enzymes),
the inclusion in the cell cultures of a
metabolic-activating system is required to
obtain toxic responses. Any artificial system
used to simulate normal metabolism of
chemicals should preferably be comparable
to the in vivo condition. Usually, bio-
chemical activation and detoxification of
test substances are simulated in vitro by the
addition ofenzyme preparations, microso-
mal additives (e.g., embryo extract or S9
liver fractions), or metabolically active cells;
however, the biotransformation processes
may be incomplete or proceed by pathways
different from those operating in intact
organisms. Inclusion ofa metabolic activa-
tion system, whether a liver microsomal
fraction, embryonic microsomes, or isolated
cells, requires a consistent source ofextract
to ensure reproducibility ofexperimental
data. The metabolic pattern is determined
by the type of metabolic system and the
species and sex from which the metabolic
competent cells are isolated. However, it
can never take into account the polymor-
phisms seen for a variety ofenzymes, some
ofwhich may be relevant to neurotoxicity
(e.g., cytochrome P450s or monoamine
oxidase [MAO-B]). It also requires the use
ofa number ofanimals to generate a bulk
preparation for continued use. Results from
studies using metabolic activation system
must be interpreted in light ofknown cyto-
toxicity resulting from the addition of
hepatic S9 fractions to neural cultures (21).
In many cases metabolism is not limited to
the liver, but also can include metabolism
by resident cells in the organ tissue ofinter-
est. For example, in the nervous system,
there is evidence that glial cells are necessary
to produce the neurotoxic metabolite N-
methyl-4-phenylpyridinium ion (MPP+)
from the parent compound 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP)
(22), to convert glutamate to glutamine
(23), and to sequester heavy metals from
the neural environment (24). Thus, in vitro
models in which the influences ofextrane-
ous chemical substances are studied are
often deficient in competent metabolic sys-
tems operating in the whole organism.
Although cell culture allows a precise deter-
mination ofthe toxic exposure delivered to
cells, it also poses a difficulty in defining a
toxicologically relevant dose.
EXPOSURE DURATION. Chemicals can
have various toxic effects on the whole
organism, depending on the exposure dose
and duration. Toxic effects may be seen
shortly after the initiation of exposure
(acute effects) or only after some delay. In
some cases, signs ofneurotoxicity may be
observed only after repeated or prolonged
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exposure. The appearance ofsuch effects
may not only depend on the type ofchemi-
cal and dose used, but may also depend
upon the biological processes underlying
the toxic response. Certain compounds
interact directly with accessible cell compo-
nents such as the cell membrane or vital
enzymes. As a result, these structures will be
functionally affected shortly after exposure.
For these effects, the peak concentration
and exposure schedule are ofutmost impor-
tance. Adelay in the appearance ofeffects is
due to the initiation of an irreversible
cascade ofreactions, after which cell dam-
age is manifested. Each step within the cas-
cade, however, needs time to initiate the
subsequent step, resulting in a delay in the
appearance of the toxic response. Pro-
gressive effects are induced by the initiation
ofa cascade ofreactions similar to delayed
effects; however, the first changes can be
observed only after a significant latency
from which the damage is progressive
intensified. In other cases, a toxic effect may
require an accumulation of a chemical
within the system for an extended period of
time rather than a peak serum concentra-
tion. An example is bismuth, which shows
no acute effects either in vivo or in vitro
even at extreme doses/concentrations.
Adverse effects become manifest only after a
prolonged exposure period (25).
Depending on the type of in vitro
system, neural cells may survive only a few
hours or several months; however, each cell
type can mature during this period. As a
consequence, the exposure window differs
among the different culture systems
because of differences in survival. The
majority of culture systems employed are
applicable for examining acute responses
but are not readily conducive to examining
any effects that are progressive or delayed
in nature.
Lack ofHomeostatic Mechanisms.
Using in vitro systems provides the
researcher with the ability to study a dis-
crete nervous system area isolated from nor-
mal in vivo homeostatic mechanisms. The
use of in vitro techniques allows the exact
and highly specific measurement ofmany
fundamental biological processes isolated
from other areas and from complicating
factors contributed by the whole organism.
In vitro systems offer much in the way of
assessing mechanistic questions in a defined
controlled system; however, it is an artificial
system, and the effects seen in vitro must be
confirmed or substantiated in vivo. The
lack ofhomeostatic influences, such as the
regulatory control of the neuroendocrine
system, nutritional support provided by the
blood circulation, interactions with adja-
cent cells, and the intercellular components
that create a unique microenvironment,
may limit the extrapolation of in vitro
results to in vivo situations.
In the whole animal, chemical dispo-
sition is influenced by several factors. The
presence ofan intact blood-brain barrier is
a major factor in determining a chemical's
access to the brain. The absence ofthis bar-
rier in culture conditions can be viewed in
two ways. It may be advantageous in that
the culture condition permits direct contact
ofa chemical with the cell, allowing assess-
ment ofthe intrinsic toxicity ofthe chemi-
cal. The lack of a blood-brain barrier in
culture, however, can also limit the extrapo-
lation ofin vitroresults to the in vivocondi-
tion. Although in vitro conditions allow a
chemical direct contact with nervous sys-
tem cells, the lack of the in vivo filtering
processes associated with the blood-brain
barrier or lipid-aqueous partitioning (26)
contributes to the artificial nature of the
culture exposure. Therefore, although cell
culture allows a precise determination of
the chemical delivered to cells, it also poses
a difficulty in defining toxicologically rele-
vant doses. It must be noted that the
blood-brain barrier is incomplete during
prenatal stages ofdevelopment and in spe-
cific regions ofthe nervous system. In addi-
tion, the permeability ofthe blood-brain or
blood-nerve barrier may be compromised
as a result of chemical exposure to either
the test compound or by induction ofother
modulating factors. This would allow pas-
sage of components normally excluded
from the nervous system.
Multiple Species Comparisons. In vitro
systems offer the opportunity for the inves-
tigator to examine similar cell types from
multiple species. One can measure
responses in cells from various species easily
when cell lines are used. The response of
human cells can be compared with that of
other species to address questions ofinter-
species selective toxicity. However, compar-
isons may be limited by the inherent
differences in the origin ofthe cell line that
are totally unrelated to species origin.
Primary cell cultures are not readily avail-
able from human tissue. Human lines are
derived from a limited number ofprogeni-
tor cells. However, the development ofnew
cell lines offers a wider variety of human
cells to examine. For example aself-replicat-
ing culture HCN-lAa was recently devel-
oped from human cerebral cortical neurons
obtained from a patient with unilateral
megalencephaly, a developmental neu-
ropathology in which immature neurons
continue to proliferate (27).
Heterogeneity ofthe Nervous System.
In vivo, the development and differen-
tiation of the nervous system depend on
the interaction between neuronal and
non-neuronal cell types. In a neurotoxic
response, not all compounds directly inter-
act with individual cells but may cause
damage by indirect effects such as modifi-
cations of cell-cell interactions. As men-
tioned earlier, what has been perceived as a
major advantage ofprimary cell cultures is
the ability to obtain a culture enriched in
one particular cell type. Such an isolated
condition is an alien state for neural cells.
Much work has focused on obtaining
enriched cultures representative of neu-
ronal populations in the brain, spinal cord,
and ganglion. With these efforts it has
been demonstrated that rarely does a neu-
ronal culture exist in the absence ofsome
glial cells and that dynamic interactions
exist between the cell types in culture
(28,29). In fact, in many cases neurons
survive poorly in the absence ofastroglial
cells (30). When early postnatal cerebellar
astroglial cells are cultured in the absence
of neurons, they show a flat, undifferen-
tiated morphology and proliferate rapidly.
The addition of neurons to such cultures
rapidly arrests glial cell growth and induce
glial morphological differentiation into
profiles resembling cerebellar astroglia seen
in vivo (31). Similar effects are seen in cells
isolated from other regions of the-brain.
Neuronal inhibition ofglial cell division
requires a neuron:glial cell ratio ofat least
4 to 1. Ifthe system falls below that ratio,
many of the glial cells remain free of neu-
rons and continue to proliferate, suggesting
the need for membrane-membrane inter-
actions. It has been reported that in culture
the inhibition ofglial cell proliferation by
neurons can be modulated by the availabil-
ity and type ofserum in the culture media
(32). Similar effects are seen with various
astrocytoma cell lines (33). Astrocytomas
pare among the most devastating CNS
tumors, ranging from the slowly growing
astrocytomas to the rapidly growing glioma
multiformae. Cell lines from these tumors
include rat C6, mouse G26-24, and
human U-251, HTB-16, and A-172 cells,
among others. Neurons plated on these
astrocytoma cells rapidly bind to the astro-
cytoma cell and inhibit glial cell growth. A
dynamic interaction between cell types has
been reported with inhibition of glia-
induced endothelial differentiation by lead
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exposure in co-cultures of C6 glioma cells
and retinal endothelial cells (34).
An example ofcellular interdependency
and influence on toxicity is the recent find-
ing ofthe in vitro toxicity oftrimethyltin
(TMT), a chemical that produces specific
neuronal necrosis in the hippocampus and
astrocyte hypertrophy, and increased
microglia staining. In a simple comparison
ofcell cytotoxicity, one finds distinct dif-
ferences in dose levels required to produce
a 50% increase in measurements ofmem-
brane permeability. Richter-Landsberg and
Besser (35) studied the toxic effects of
TMT on primary astrocytes isolated from
1- to 3-day-old neonatal rats and used neu-
tral red assay to determine cell viability.
They reported a dose of2.5 pM TMT for
half-maximal cytotoxicity in primary astro-
cytes treated for 24 hr. The toxicity of
TMT on primary cultures derived from 1-
day-old rat pups containing both astrocytes
and neurons was higher with a half-maxi-
mal cytotoxicity in primary glial cells of 5
pM as measured by ethidium-calcein via-
bility assay and by immunofluorescence
(36). A third study examining the toxicity
ofTMT on a mixed glial population in
culture (37) reported approximately a 30%
decrease in cell viability at 10 pM TMT
within 24 hr as measured by neutral red
assay and lactate dehydrogenase (LDH)
release. Given the steep nature of the
dose-response curve for lethality in vivo,
these differences in vitro raise concern.
Although each study derived cells from rat
pups within the designated time ofpostna-
tal day 0 to 2, there were several differences
in the conditions of the culture. In the
Richter-Landsberg and Besser study (35),
the standard protocol for isolation of rat
brain glial (38) was followed, which
required a defined region ofthe cortex to
be used for isolation. The initial cell prepa-
ration was grown for 2 weeks in flasks in
serum-containing medium, followed by
shaking to remove both microglia and
oligodendroglia. The remaining cells were
replated in 24-well culture dishes and used
for toxicity studies within 2 days. In the
study by Maier et al. (37), mixed glial pre-
pared from postnatal day 2 rat pups by the
method ofMcCarthy and de Vellis (38)
were allowed to grow in tissue culture
flasks for 2 weeks in medium containing
fetal calfserum. They were then replated
into 24-well culture dishes in which they
were allowed to mature until 14 days in
vitro. This 14- to 21-day period following
replating is consistent with all neurobio-
logical studies conducted on astrocytes and
can be critical to the maturation state of
the cells and the proportion ofcells differ-
entiated into oligodendroglia, astrocytes,
and microglia. Thus, the difference in sen-
sitivity could be due to the cellular pop-
ulation within each culture and the
interactions between each cell type, the
brain region from which the cells were de-
rived, the maturation state of the cells at
the time of toxicant exposure, the sub-
stratum on which the cells were plated, and
the presence ofserum.
During development, neurons and glial
cells may interact by influencing differentia-
tion. The anatomical organization ofastro-
cytes and their ability to take up and
metabolize synaptic transmitters suggest
multiple functions for astrocytes in synaptic
transmission (39-41). Glial cells extraneur-
onally regulate neurotransmitter con-
centration, thus potentially influencing the
neurons (42-44). Numerous studies on the
glutamine-glutamate neuronal-glial cycle
suggest that glial cells act as modulators of
neuronal activity (45). Glial cells may play
an important role in maintenance of neu-
ronal glutamate metabolism in cells that use
glutamate as a neurotransmitter. Based upon
the cellular localization ofglutamine syn-
thetase in glial cells (46,47) and glutaminase
in neurons, a cycle has been proposed in
which glutamate released by the neuron is
taken up into astrocytes by a high-affinity
uptake system (48,49). Once in the astro-
cyte, glutamate is converted to glutamine by
glutamine synthetase and released. It is then
taken up by the neuron and reconverted by
glutaminase into glutamate. Gamma-amino-
butyric acid (GABA) is released from astro-
cytes upon glutamate receptor stimulation
(50) andcould inhibit neuronal signaling. In
models ofchemical-induced glutamate excit-
otoxicity, any examination ofneuronal cells
in the absence ofglia would be problematic.
Glial cells contain the enzyme monoamine
oxidase B (51-53). Thus, any chemical re-
quiring local metabolism in the brain for its
toxicity would not be detected in cultures
devoid ofglial cells, although such a culture
condition is highly unlikely even at a high
level ofneuronal purity.
The role for astrocytes in neurotoxic
responses has been supported in primary
cell culture studies. Astroglia accumulate
lead from the culture medium and con-
centrate it to levels as high as 1000-fold
above the extracellular level (54). Similar
reports exist for sequestration of iron in
astroglia (55). Quantification of intra-
cellular metal levels by graphite furnace
atomic absorption spectroscopy requires a -
minimum of2 million cells persample, thus
limiting the number ofsamples available for
analysis. Ofinterest are the observations that
glia in mixed cultures containing other cell
types respond differently to lead than either




Practical uses of in vitro systems have been
established for development of pharma-
ceutical agents. In general, pharmacological
agents are designed to act by a specific
mechanism at a receptor site. Depending on
the target site involved, one can develop a
specific in vitro system that will allow for
testing ofdrug efficacyand potency. In addi-
tion, information acquired during drug
design, site of action of the drug being
tested, and any confounding sites ofaction
that would change the drug potency could
lead to additional testing in focused systems.
This is a unique environment in which a
drug is designed to workvia aspecific mech-
anism; because this information is known, in
vitro tests can be designed to evaluate this
specific mechanism. The use ofin vitrotech-
niques to identify a drug for development,
refine a drug's action and detect problems
with a drug such that developmental costs
can be minimized are all worthwhile in an
environment where a mechanism ofaction,
the target cell type(s), and/or cell functions
are generally known. However, in vitro tests
are not generally amenable for assessing
potential unexpected or unknown drug side
effects and testing is conducted in animals
prior to human clinical trials.
A well-characterized mechanism for
neurotoxicity is excess release ofthe excita-
tory neurotransmitter glutamate. Gluta-
mate excitotoxicity is mediated, in part, via
activation of postsynaptic N-methyl-D-
aspartate (NMDA)-type glutamate recep-
tors. Cells that possess these receptors are
susceptible to excitotoxicity; excess receptor
stimulation leads to prolonged influx of
sodium and calcium. This influx triggers a
cascade ofevents that ultimately leads to cell
death (58). Several glutamate analogs such
as domoic acid also produce an excitotoxic
lesion. Domoic acid accumulation in shell-
fish has caused outbreaks ofhuman amnesia
via loss ofhippocampal and neocortical neu-
rons, which are sensitive to activation ofthe
glutamate receptor.
Identification and understanding of
this mechanism ofexcitotoxicity has been
aided by the use ofa variety ofin vitrosys-
tems. Hippocampal slice preparations and
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organotypic cultures have been used to
study electrophysiologic, biochemical, and
pharmacologic consequences of NMDA
receptor activation. Primary dispersed hip-
pocampal and neocortical cultures are also
used for characterizing excitotoxicants.
Finally, both Xenopus oocytes and several
neuroblastoma-derived cell lines have been
transfected with expression vectors direct-
ing production of neurotransmitter recep-
tors. Expression of such receptors in cell
lines allows additional characterization of
receptor responses in a different cellular
context. The key reason for success in
studying the NMDA receptor in vitro was
the clear identification of the mechanistic
target for glutamate agonists and antago-
nists. Clearly, unknown chemicals can be
evaluated for excitotoxic properties in vitro
using glutamate receptor-bearing cells.
However, other, nonglutamate-mediated
toxicity may be missed.
The situation as presented for pharma-
ceutical agents does not always exist in the
development ofchemicals used in agriculture
or industry. One exception to this statement
is certain insecticides designed to act at ion
channels in the nerve membrane. The
pyrethroid insecticides provide an example
ofpesticides which are neurotoxic but not
cytotoxic. There is a reasonable correlation
between increased transmembrane sodium
flux and neurotoxicity, but pyrethroids have
litde or no effect on neuronal viability (59).
Another successful application ofan in vitro
or ex vivo test is the prediction ofthe delayed
neurotoxic potential of certain organo-
phosphorous pesticides and industrial chem-
icals by measurement ofneuropathy target
esterase (NTE). The ratio ofNTE aging to
acetylcholinesterase (AChE) inhibition can
be measured in normal brain homogenates
or in cell cultures. This provides aprediction
ofthe relative acute toxic and delayed neuro-
toxic potential ofthese agents. An illustra-
tion ofthe importance ofbioactivation is
provided by the organophosphates. The sul-
fur form (e.g., parathion) has very little toxic
potential until bioactivated to the oxon form
(e.g., paraoxon). This capacity ofbioactiva-
tion is lacking in the absence of in vivo
mechanisms and therefore remains unde-





To conduct reliable in vitro studies, one
must provide and adhere to certain specific
requirements to ensure healthy repro-
ducible neural cell cultures. One major
requirement that distinguishes in vitro
techniques from other laboratory methcds
is the need to maintain asepsis. Aseptic
functions that occur in the cell culture lab-
oratory include culture preparation, incu-
bation, and handling. The cell culture
laboratory should have access to steriliza-
tion methods appropriate for media,
instruments, and biological wastes. The use
oflaminar flow cabinets with a continuous
movement ofsterile air over the work area
provides a relatively low-cost environment
under which cultures may be collected and
manipulated. Further control of the cell
culture environment (temperature, oxygen
tension, carbon dioxide content) is critical
and is generally provided by the use ofcell
culture incubators with uninterrupted
power supplies. Most cell culture laborato-
ries have access to refrigerated storage (4 to
-20°C) capable ofstoring media and other
reagents, as well as liquid nitrogen freezers
for long-term storage of neural cell lines.
An inverted phase-contrast microscope or,
in the case ofglial cells, a microscope with
three-dimensional optics such as Hoffman
or Nomarski, is vital to allow morpho-
logical assessment ofneural cultures. Access
to specialty chemicals, sterile pipettes,
glassware, and cell culture vessels is also
critical for a cell culture laboratory. Other
equipment generally required includes
refrigerated centrifuges, cell counters
including hemocytometers, and pipetting




It has been well established that in any
culture system the cellular phenotype is
influenced by culture conditions. In vivo
growth and differentiation of cells is
dependent upon a complex set ofenviron-
mental influences that include nutritional
and hormonal factors, the nature of the
substratum to which the cells adhere, and
cell-cell interactions. Attempts have been
made to mimic the in vivo condition with
improvement and diversification ofculture
media and substrata. However, to produce
a cell in culture that is identical to its in
vivo counterpart, all external influences
must be adequately mimicked.
Cellular Heterogeneity. In primary
cultures the initial cell population is
extremely heterogeneous, and it is impos-
sible to obtain a group of cells in culture
that is completely representative ofthose in
vivo. For some specific questions, it may be
desirable to have cultures ofonly one cell
type. These cultures can be obtained from
distinct brain regions by selection ofdonor
optimal age. Once growing in culture, a cell
type ofinterest can be selected by a variety
ofmethods. For example, a cytotoxic anti-
serum may be used to kill one class ofcells;
deletion ofa critical hormone could selec-
tively eliminate a cell type. Glia and fibrob-
lasts are frequently decreased by the use of
DNA synthesis inhibitors that kill only
dividing cells. Other methods, such as those
used for glial cells, include manipulation of
serum concentration in the media, and dif-
ferential cell adhesion. All ofthese methods
will aid in the purification process; how-
ever, no method has been found to ensure
the absolute cell purity ofthe culture. The
ability to provide a cell type-enriched cul-
ture offers a primaryadvantage over dissoci-
ated cell cultures. This offers the possibility
to make biochemical measurements on
large numbers ofcells rather than on a sin-
gle cell. Whether the results obtained from
these pure cell cultures will be reflective of
the in vivo condition is uncertain.
As growth conditions often may select
for some phenotypes versus others, it is
essential that the conditions ofdissociation
and culturing be identical for each experi-
ment to ensure reproducibility. With het-
erogeneous CNS tissue, it is unlikely that
the final cell population will reflect the ini-
tial population. The composition ofa cul-
ture can change drastically with time if
some of the cells in the population con-
tinue to divide. The more rapidly dividing
cells will have a selective advantage over the
nondividing cells. If one is using cloned
cells from an original culture, the clones
are limited in the number oftimes they can
divide. Thus it is necessary to periodically
isolate new clones. Phenotypic drift often
occurs and mutant cells are difficult to
identify in primary cultures.
Serum versus Chemically Defined
Medium. Currently, most cultured cells are
kept in media containing serum plus a basic
nutrient mixture ofrequired sugars, salts,
amino acids, and vitamins. Serum contains
additional growth hormones and growth
and attachment factors. Attempts to fully
mimic these components have been
difficult. Chemically defined serum-free
media have been devised for many cell lines
and primary cell cultures. These media
may contain salts, vitamins, amino acids,
growth factors, hormones, and adhesion
molecules specific to each type ofcultured
cell, and do not necessarily generalize to
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other cells (60). Chemically defined media
conditions have tempered the troublesome,
uncontrollable, and undefined nature of
sera, as well as problems ofstandardization
and reproducibility ofresults with various
batches ofsera. However, it can be assumed
that any extraneous supplementation will
be minimal compared to the contribution
ofvarious components available in vivo.
Because ofvarious developmental factors
present in the nervous system and limited
knowledge ofextracellular influences, fully
defined media is very different from the in
vivophysiological milieu ofthe cell.
Given the variety ofmedia and supple-
ments, one needs to be aware of the
extreme variations in cellular metabolism
and gene expression that can result under
different media conditions. For example,
the metabolism ofepidermal growth factor
(EGF) varies as a function ofserum. EGF
remains on the membrane surface ofcells
grown in a defined serum-free medium fac-
tor but is internalized in the presence of
serum. Synthesis ofglial fibrillary acidic
protein (GFAP) and microtubule-associ-
ated protein by neural cells is influenced by
both serum concentration and animal
source. Adrenal cortical cells grown in
medium supplemented with horse serum
secrete large amounts ofcorticosterone but
display a different morphology in fetal calf
serum and produce only 1% ofthe steroid
as made by cells in horse serum. The phe-
notype cannot be reversed bymanipulation
ofserum type in the culture medium.
Cell Substratum. The substratum on
which cells are cultivated contributes greatly
to their metabolism and division. Frequently
collagen, fibronectin, poly-D-lysine, poly-
ornithine, and highly sulfonated tissue cul-
ture plastic are used as cell substrata. Some
cells are anchorage dependent (i.e., require
an adhesive surface on which to adhere)
whereas others proliferate/differentiate
either loosely attached, or in suspension as
reaggregates. Ifcells are grown under condi-
tions in which their state ofadhesion is
experimentally varied, many biochemical
characteristics ofthe cells also change. For
example, poly-D-lysine is used often in
neural cell cultures, to increase cell-substra-
tum adhesion. Many times poly-D-lysine is
used to assure the continued attachment of
cells throughout the washes required in vari-
ous experiments such as precursor uptake
studies, enzyme assays, or binding ofiso-
topically labeled ligands to cell-surface
receptors. Even for cell viability studies of
dye uptake, maximizing the attachment of
viable cells to the substratum is critical to
experimental outcome. Although poly-D-
lysine is often used, it can cause a number
ofphenotypic changes in cells, including
changes in morphology, ultrastructure, and
metabolism. Because cell-poly-D-lysine
interaction can alter cAMP synthesis and
interfere with normal ion channel function-
ing, this substratum should not be used
with cells for electrophysiological experi-
mentation. These effects are likely due to a
direct and global action ofthe polycation
on the cell membrane rather than to any
specific modifications of the particular
phenotypic trait beingexamined.
With cells that can be grown either in
suspension or attached to a surface, differ-
ences in metabolism can be observed. In
fibroblasts, various amino acid transport
systems are used, depending on whether
the cells are attached or suspended. Fibro-
blasts that are grown attached to a surface
contain 5 times as much of the protein
tubulin as cells grown in suspension.
Substrate-attached fibroblasts are also more
sensitive to cytolysis by antisera against the
cell surface, although the actual number of
cell-surface antigens is the same in both
culture conditions. The substratum can
regulate cell morphology and division rate.
Fibroblast-like cells grown on culture plas-
tic are flat and elongated and divide rapidly.
The same cells grown on hydrophobic
bacteriological plastic do not attach, are
round in shape, and divide very slowly if
at all. Experiments conducted on this reg-
ulation of division and morphology
demonstrated that differences in the cells
were not minor; fibroblast-like cells can ini-
tiate DNA synthesis only when they are
sufficiently flattened on the substratum.
Cell Feeding. During the routine
replacement ofculture medium or "feed-
ing," problems can arise from inconsistent
cell culture techniques. Cellular phenotype
can be altered in some cells by the addition
of new culture medium or the manipu-
lation associated with medium replacement.
Therefore, care must be taken to insure that
experimental effects can be distinguished
from those caused by the addition ofnew
medium. For example, with the addition of
new medium, endothelial cells decrease
plasminogen activator activity. This appears
to be due to an inhibitory factor in the
serum ofthe medium. It has been proposed
that this effect can be circumvented by the
use ofchemically defined, serum-free cul-
ture media; however, with neural cells,
addition of new growth factors in added
medium or dilution ofa released growth
compound by media exchange may also
present a transient change in the cell
phenotype. As a result ofculture medium
replacement, the pH ofthe medium may
rise transiently above 7.4. The processes
induced at this pH are somewhat similar to
those induced by growth factors. Partial
replacement or methods to limit the need
for medium replacement can partially
overcome theseproblems.
Oxygen Tension. Atmospheric oxygen
tension is a critical component that must be
maintained for the culturing ofnerve cells.
In the majority ofpublished protocols, the
atmosphere ofthe cell within an incubator
is maintained at a ratio of95% air to 5%
carbon dioxide. The viability ofcerebral
cortical neurons and the proliferation and
maturation ofastroglia cells is maximized at
10% partial pressure ofoxygen (61).
Cell-Cell Interactions. Because of
differences in cell-cell interactions, differ-
ences in metabolism and degree ofdiffer-
entiation can be observed between cells
grown as reaggregates or attached to a sur-
face. A simple example is the dramatic alter-
ation in cellular physiology depending on
the aggregation state ofcells. An example of
cell-cell contact in the regulation ofhor-
mone receptor function has been demon-
strated in neural retina cells maintained in
reaggregate cultures. The cytoplasmic corti-
sol receptor was decreased and the enzyme
glutamine synthetase was not inducible by
cortisol. However, in reaggregate cells the
cortisol receptors are detectable and the glut-
amine synthetase is inducible at levels similar
to in vivo.
Cell Cycle. The overall rate ofprotein
synthesis is similar between dividing and
stationary-phase cells; however, the rate of
synthesis for about 40% ofspecific proteins
varies as a function ofcell phase. Therefore,
experimental protocols involving reagents
which alter cell cycle (e.g., antimitotic
drugs) must be designed to distinguish
between the primary experimental effect
and the secondary consequences ofaltering
the growth cycles ofthe cultures. Cell phe-
notypic changes are also associated with the
cell cycle. Cells vary not only among differ-
ent growth phases ofthe culture but also
throughout the cell cycle. Under normal
proliferative conditions, macromolecular
synthesis in exponentially dividing cells is
always quantitatively different from that in
stationary-phase cells.
Age. The donor animal and duration of
the culture period are both critical parame-
ters in many organotypic, reaggregate, and
dissociated primary cultures. Most attempts
at primary culture ofnervous tissue have
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involved the use offetal or neonatal mater-
ial because of the difficulties in initiating
cultures from the adult vertebrate CNS.
These difficulties arise from the destruction
ofthe neurites during cell isolation/prepa-
ration procedures and removal of cells
from the projection areas. Because ofdif-
ferences in timing ofdevelopment in vari-
ous brain regions, neuronal cultures from
each brain region have been successful only
within a distinct identified age period.
Even within the same brain region, indi-
vidual cell types require distinct donor
ages. For example, from rat brain cere-
bellum, granule cells are isolated from
postnatal day 6 to 8 brain, but successful
Purkinje cell cultures require isolation from
fetal tissue. Glial cell cultures offer a
broader window of age from which suc-
cessful cultures can be obtained. Greater
success has been achieved in culturing
components of the PNS where primary
cultures may be maintained from adult and
even aged donors (62,63).
Neuronal cultures differ dramatically in
the composition ofglial cells, the matura-
tion ofthe glia, the proportion ofglial cell
types, and the biochemical responsiveness
ofthe culture. Although glial cultures can
be generated from different ages, it is criti-
cal to the interpretation ofexperimental
data that the donor age be maintained
within a well-characterized biologic and
morphologic window. For cortical astro-
cytes and oligodendroglia, this is between
birth and 2 days postnatal. For each of
these cell types, the culture age is critically
important with regard to the responsiveness
ofthe culture to manipulation. Although it
has been claimed that primary nerve cul-
tures can be maintained for several months
by using supplemented nutrient media and
a substrate that supports adhesion, it is well
known that the metabolic properties ofthe
cells will change over time. Factors ofdonor
age, as well as age ofthe culture, must be
addressed whenever primary culture sys-
tems are used to determine pharmacological
or toxicological responses to various agents.
Slice cultures are prepared from infant
animals with the age ofthe donor is a criti-
cal parameter in the degree oforganotypic
organization achieved in the final prepara-
tion. Usually, tissue is obtained from rats
within the first week oflife. By that time, a
fair degree of tissue-specific cytoarchitec-
ture has already been established and the
peak of neuronal migration has passed.
Within 2 to 3 weeks in culture, an original
slice will thin to form a pseudomonolayer
of cells and the degree of maturation and
differentiation can be determined prior to
experimental manipulation. For ex vivo
studies, tissue can be obtained from any
age animal; however, the maturation ofthe
region of interest prior to sampling and
interpretation ofdata must be considered.
Continuous cell lines are usually derived
from tumorigenic tissue and can be
obtained from donors ofvarious ages. In
culture, these types ofcells have a useful life
span ofapproximately 50 divisions charac-
terized by progressively longer time periods
between population doubling. Immortalized
cell lines are generated from cell lines of
limited life span that undergo crisis after
which their growth potential changes and
the life span becomes unlimited. Clonal pri-
mary cultures are derived from the progeny
ofa single cell, but the cells are limited in
the number ofdivisions they can undergo.
Once the cell line phenotype is established,
it does not change; however, with increasing
passages it slowly drifts with regard to
physiological responsiveness.
The sensitivity ofany culture to toxi-
cants can be influenced by the age ofthe
culture. Whether it is the influence ofpas-
sage number in continuous cell lines, mat-
uration and establishment ofconnections
in a reaggregate culture, or the cellular
maturation ofprimary cell cultures, each
culture model requires that any experi-
mental manipulation be conducted at an
optimal and consistent age in culture. For
example, the toxicity of MPTP to
dopaminergic neurons is significantly
greater in fully developed dopaminergic
neurons and toxicity that is dependent
upon ion channel activity will require the
maturation ofthis physiological process for
detection and examination.
State ofDifferentiation. Since many of
the sources oftissue for primary cultures are
from fetal or early postnatal animals, fea-
tures ofadult differentiated neurons or glial
cells may not be present. Examples include
cerebellar granule cells and dentate gyrus
neurons; both cease division postnatally and
do not express ion channels until several
days in culture. In neuroblastoma and
related cell lines, trophic growth factors alter
the state ofmorphologic differentiation and
overall gene expression. Well-characterized
examples include nerve growth factor
(NGF)-induced differentiation of rat
pheochromocytoma (PC-12) cells and
retinoic acid-induced differentiation of
human neuroblastoma cells (SMS-KCNR;
SNSY5Y). In both instances, treated cells
extend complex neurites, express new
neuronal cytoskeletal elements, and show
prominent shifts in gene expression and
slowed or arrested cell division. The state of
differentiation can clearly affect expression
ofpotential targets ofneurotoxicity.
Characterization. In specific cases, one
requires a relatively pure culture of neu-
ronal or glial cells. To determine the purity
ofa culture, one must examine the culture
not only microscopically for structural fea-
tures but also by immunocytochemical
methods to identify individual cells con-
tributing to the culture. A problem central
to all culture systems is cellular impurities
and culture heterogeneity. It is, therefore,
essential that both the characteristic mor-
phology and antigenic phenotype of the
cultured cells be characterized to permit
the unique identification ofthese cell types.
These may include either immunocyto-
chemical or enzymatic markers that are
associated with the plathora of CNS cells
(Table 2).
One possible contaminating cell in any
primary cell culture is the fibroblast.
Attempts are made to eliminate this cell
type from neural cultures by removing all
brain meninges prior to dissociation, pre-
plating for early adherence removal, and
adding cytotoxic agents for proliferating
cells. The case is similar for glial cells as a
contaminating factor in neuronal cultures;
however, detection ofall types ofglial cells
requires the use ofa number of antibody
evaluations. One ofthe major concerns with
contributing glial cells is the surface area of
the glia relative to neurons. Although one
may determine by counting number of
cells that glia contribute less than 5% of
the culture, each one ofthese cells has the
surface area ofhundreds ofneurons. With
glial cultures, the use ofdifferential adher-
ence or gradient fractionation aids in the
generation of enriched cultures of indi-
vidual glial cells. However, recent evidence
suggests that factors previously contributed
by astrocytes are the product of contami-
nating microglia cells within the culture
preparation. As little as 1% contribution of
microglia can significantly influence the
interpretation of data derived from astro-
cyte cell cultures. Not only must the cul-
ture system be characterized in use with
regard to contributing cell types, but the
maturation state ofthe specific cell type of
interest must be determined. For example,
during maturation, glial cells-both astro-
cytes and oligodendroglia-will progress
through distinct periods ofsurface antigen
expression, and the use of the standard
antibody staining to GFAP may not detect
all contributing astrocytes.
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Table 2. Cell types and immunohistochemical markers.
Cells Markers






































Surveillance. Antibiotics and/or fungi-
cides often are added to a cell culture prepa-
ration to prevent contamination. Such
additions can reduce cellular activity and
modify drug-induced neurotoxic effects.
Unlike bacteria and fungi, contamination
ofmycoplasma usually does not result in
turbid growth or macroscopic alterations of
the cells. However, mycoplasma contami-
nation may cause adverse effects such as
changes in metabolism, growth, viability,
DNA, RNA, protein synthesis, morphol-
ogy, and virus propagation, thus leading to
unreliable experimental data. For example,
in a mixed glial preparation containing
microglia, any contaminating factor will
activate the microglia into phagocytic activ-
ity. The source ofcontamination mayorigi-
nate from initial culturing techniques and
in the case ofa cell line can be propagated
among a number ofresearch laboratories.
As a quality control measure, all culture
systems should be evaluated for the presence
of any bacterial, fungal, or mycoplasmic
contamination prior to use.
Other Culture Condition Factors.
There are a number ofother factors unique
to culture systems that raise concern for
neurotoxicologists. For example, the viabil-
ity and plating efficiency (number ofcells
that attach to the substratum with initial
plating) ofindividual cells is greatly influ-
enced by the technical manipulation ofthe
cell source. For primary cultures, the
method ofdissociation has a major influ-
ence. Enzymatically dissociated cells
generally survive better than those dissoci-
ated by mechanical means. It has been sug-
gested that at early prenatal stages a
mechanical disruption of cells produces
greater cell survival and enzymatic disrup-
tion produces greater survival ofcells iso-
lated from late prenatal and postnatal ages.
For cell lines, the storage condition ofthe
cells (e.g., frozen in DMSO or glycine, by
quick or slow method, in media or buffer)
and methods ofplating can influence the
proportion ofcell viability. For each culture
system, these factors can influence greatly
the ability to compare experimental data
across various laboratories using different
techniques or different cell sources.
In summary, culture systems offer the
potential advantage ofexamining a direct
cellular response to a chemical, determin-
ing biological processes at a level that
would not be accessible in vivo, and assess-
ing underlying mechanisms associated with
cellular development and functioning of
the nervous system. Although chemicals
can be easily added and withdrawn from
the cultures, and their effects directly
probed in culture systems, caution should
be used when correlating effects occurring
in vitro to those observed in the intact ani-
mal, where additive interactions are likely
to occur. One must remember several con-
cepts: a) A number ofdifferent, sometimes
competing, processes influence the ability
of a toxin to attack and destroy specific
cells. Metabolism ofthe administered agent
by a nontarget cell or tissue may be respon-
sible for bioactivation or detoxification of
the compound or its metabolite, affecting
the vulnerability ofthe cells to the neuro-
toxin. b) A cell culture is simpler and much
more homogeneous than any tissue, in par-
ticular the CNS. Removal of many cell
types and barriers can facilitate diffusion or
even active transport ofthe compound or
its metabolite, limiting or enhancing toxic-
ity by determining at which sites the toxin
can reach sufficiently high concentrations
to interfere with vital cellular processes.
c) The capacity of the cell to repair or
replace damaged organelles or enzymes can
also be critical in determining cell survival
after toxic insult and maydepend on neigh-
boring cells and physical barriers, which
would be absent in the culture.
Although culture systems are relatively
convenient to use, their ability to predict the
neurotoxicity ofa chemical in situ or the
potency of a series ofstructurally related
analogs depends on whether the culture sys-
tem expresses the target for a given neuro-
toxic effect. Anyculture system derived from
resident cells ofthe nervous system repre-
sents an artificial system with regard to the
in situ condition. Therefore, any experimen-
tal use ofsuch systems to address specific sci-
entific questions requires thatprecautions are
taken to ensure biological relevance, validity
and reliability ofthe data. Data generated
from in vitro studies must be interpreted
within the limits and framework of the
experimental design. In vitro studies are
relevant only ifthe target site is contained
within the culture model. Any extrapolation
to the in vivo condition must take into con-
sideration modulating factors that are pre-
sent in the whole animal, e.g., blood-brain
barrier, lipid partitioning, metabolic
activation, ordetoxification ofachemical.
Model in ViroSystems
Introduction. All cell culture systems
represent cells that are no longer part ofan
integrated neural network and may develop
an altered appearance, metabolism, and an
altered response to test chemicals (Figure 1).
There are numerous vertebrate primary cul-
ture systems representing a specific region
or cellular component ofthe nervous sys-
tem. Historically, the first organotypic cell
culture system was based on fragments of
nervous tissue from frog embryo placed in a
drop ofclotted lymph tissue. This system
demonstrated that each nerve axon or den-
drite is an extension of the neuronal cell
body. These studies became the prototype
ofthe explant cell culture technique. The
second technique, dissociated cell culture,
was first introduced in the 1960s. In this
method, the tissue is dissociated mechani-
cally or enzymatically, resulting in a sus-
pension ofdispersed cells. These cells are
then cultured on substratum in a culture
dish. A third system, reaggregate cell cul-
ture, was initiated to provide a tissuelike
environment for the cells. In this method,
the dissociated cells are placed in a rotating
flask and small round aggregates are found
floating in the media. A fourth system is
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that of clonal cell culture lines, which is
established by culturing the progeny of a
single cell. Neural cell lines come from
endogenous tumors or from chemically or
viral transformed cells; tumorigenic proper-
ties ofthese cell lines present obvious limi-
tations to their usefulness. Efforts to use
human cell lines within neurotoxicology
have been limited by the atypical nature of
the cells, for example, their expression of
high levels ofglutathione (20).
Uses andLimitations. For examination
ofaltered nervous system functioning, iso-
lated models have been selected that con-
tain key biochemical and morphological
features which are specifically targeted by
neurotoxicants in vivo. Each type oftissue
culture system to be discussed has its own
specific advantages and disadvantages
(Table 3). Dissociated cell cultures allowfor
visualization of individual living cells and
for monitoring both morphological and
electrophysiological features. Although the
histotypic tissue organization is lost as a
result of the dissociation procedure, it is
believed that neuronal and glial cells
migrate to rearrange themselves on the
substratum and differentiate according to
their function and abilities. However, in
vivo-like structures cannot be obtained by
this technique. Dissociated cell cultures are
more accessible to experimental mani-
pulation than slice cultures and are easier to
obtain and maintain. It is possible to obtain
and correlate biochemical, morphological,
electrophysiological, and molecular data
from a single cell. Additional purification
methods can be used to enrich a particular
cell type in a dissociated cell preparation,
but it is difficult to obtain and define pure
cultures ofany one cell type.
Reaggregate cultures offer a more
structured, three-dimensional extracellular
space that more closely approximates the in
vivoconditions for cell growth and develop-
ment. Initially, the cells inside an aggregate
are distributed in a random fashion fol-
lowed by reorganization into a pattern for-
mation similar to the in vivo structure.
These preparations emphasize the impor-
tance ofcell contact and histotypic organi-
zation by identifying markers induced in
specific cells similar to in vivo yet absent in
dissociated cell cultures (e.g., glucocorti-
coid-induced glutamine synthetase in reti-
nal glial Muller cells). In hopes ofsimilar
biological advantages, some laboratories use
three-dimensional matrix cultures made
from components such as collagen and
fibronectin. Clonal cell lines oftumoral ori-
gin provide homogeneous cell populations
in large quantities in a very reproducible
manner. Usually the common cell lines of
choice are those that continue to express in
culture the differentiated properties oftheir
normal cell counterpart.
It must be noted again that these cell
culture systems represent cells that are no
longer part ofan integrated neural network
and may develop an altered appearance,
metabolism, and an altered response to
chemicals. Some believe that these con-
cerns can be addressed by experimental
design and choice of end points. No such
High-
Low-
Figure 1. Model culture systems.
efforts, however, will compensate for the
isolation of a system from the natural
neural environment and all ofthe systemic
influences on that environment. The abil-
ity ofculture systems to predict the neuro-
toxicity ofa chemical in situ or the potency
of a series of structurally related analogs
can depend on whether they express the
target for a neurotoxicant's action.
Types ofCulture Systems Used in
Neurotoxicology. ORGAN CULTURES. Large
parts ofthe spinal cord, ganglia, or sensory
organs (e.g., eye) can be maintained as
organ cultures. Other neural organs are dif-
ficult to perfuse in a physiological manner,
if at all. An example ofan organ that has
been studied using tissue culture is the eye.
In these experiments, the eye is isolated
under anesthesia and cannulated at the
ophthalmociliary artery (64,65). A test sub-
stance can be introduced or washed out by
the perfusion solution via the cannula.
Effects caused by the administration of a
chemical are usually measured by electro-
physiological techniques. In the eye the
reference electrodes are positioned at the
Table 3. Cell culture conditions.
Cell dissociation technique
Mechanical vs enzymatic
Source and original donor
Species - rat, mouse, human
Passage - clonal cell line









Serum vs chemically defined medium
Sera source - bovine, horse, calf, fetal
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cornea and at the posterior pole. Standing
potential, electroretinogram, and light peak
recordings are made using a glass pipette
placed in thevitreous humor.
It is assumed that the concentration of
a test substance at the target cells is compa-
rable with the in vivo situation ifthe con-
centration in the perfusate is the same as
that in the bloodstream. A further advan-
tage is that electrophysiological effects can
be measured without knowing the target
cell type. The disadvantage is that for any
individual organ, recordings can be made
for only a limited period of time. In the
case ofthe eye this time period is a maxi-
mum of6 hr. Therefore, only acute effects
can be measured. It is notpossible to deter-
mine the reversibility ofthe induced effects
beyond this limited time period.
EXPLANT/SLICE CULTURES. Organo-
typic cultures are derived from explants of
relatively undifferentiated embryonic
brain, spinal cord, or sensory organs and
develop into integrated neuronal and glial
populations. For some regions of the
nervous system, the age ofanimals used in
explant cultures can vary from embryonic
to postnatal periods but must remain
constant across comparisons (66). The
tissue explant may be a thin slice, a chunk,
or the complete organ, as is the case for
the sympathetic ganglia. The main advan-
tage of this system is the presence of a
three-dimensional organization in which
some of the organ's structural and func-
tional characteristics are retained. The
organotypic explants/slices can survive in
culture for a week to months, depending
on the culture conditions. The disadvan-
tage is the difficulty in quantifying small
changes in differentiation or viability,
depending on the parameters measured.
The nutrient supply (e.g., oxygen, media
compounds) available to the cells within
the slice/explant is dependent on the diffu-
sion rate and is governed by the thickness
of the slice/explant. Often, depending on
the thickness of the slices after prolonged
culture periods, a hypoxia in the center of
the tissue resulting in necrosis cannot be
precluded. Only in a small layer ofthe tis-
sue is it possible to maintain in vivo-like
physiological conditions.
The goal ofthis culture technique is to
obtain a preparation with a high degree of
cellular maturation and differentiation and
with an organotypic organization with the
ability to assess individual neurons. The
roller-tube technique first used with ner-
vous system tissue has allowed preparations
to be maintained in vitro for prolonged
periods oftime. These systems can be used
to study processes involved in nervous sys-
tem development such as specificity of
axonal growth and the mechanisms involved
in target contact. Organotypic slice cultures
retain, at least for a limited period oftime,
important organizational features ofthe
original tissue and allow for the morpholog-
ical identification ofspecific cell types as
well as the electrophysiological responses.
Given the massive denervation and cell
death caused by the explantation procedures
and the novel influences ofthe tissue culture
environments, it cannot be assumed that the
properties oforganotypic cultures are identi-
cal to their in vivo counterparts. What can
be experimentally exploited, however, is any
particular property ofthe cell that is the
same under both in vivo and in vitro condi-
tions. This culture technique has proven
worthwhile in the use ofsympathetic gan-
glia cultures to characterize and purify NGF
and in the rat hemidiaphragm preparation
to study reinnervation and rate ofacetyl-
choline receptor (AChR) turnover. These
cultures have been helpful in solving several
problems that could not be addressed in
animal experiments.
Slice cultures are prepared from infant
animals; the age ofthe donor is a critical
parameter with regard to the degree of
organotypic organization achieved in the
final preparation. Usually, tissue is obtained
from ratswithin thefirstweekoflife. Within
this time, a fair degree oftissue-specific
cytoarchitecture has already been established
and the peak ofneuronal migration has
passed. Within about 2 to 3 weeks in cul-
ture, an original 400-pm thickslice will thin
to form apseudomonolayer ofcells andwith
contrast enhancingoptic, the individual neu-
rons can be observed in the living state. The
results ofhypoxia and necrosis can be seen at
the center ofthe explant due to its thickness.
Microscopic examination ofindividual cells
is limited by the thickness ofthe explant.
When using slice culture techniques, the
degree ofmaturation and differentiation
must be determined under the culture con-
ditions used. There is a high likelihood of
synaptic rearrangement which must be
examined using histological techniques.
Morphological differentiation can be evalu-
ated by cellular injections with dyes such as
LuciferYelloworhorseradish peroxidase.
In many cases, the organotypic culture
provides direct access to the neurons and
allows placement ofstimulating and record-
ing electrodes. A number offeatures ofthe
slice culture make it attractive for evalu-
ating the electrophysiological activity of
individual cells and determining the effects
of various pharmacological agents. The
presence offunctional synapses needs to be
assessed by electrophysiological recording
techniques that require sophisticated
methodologies and critical controls such as
temperature. Both the excitatory and the
inhibitory systems need to be evaluated.
Receptor activityhas been studied in various
organotypic slice cultures. Such receptor
studies include excitatory amino acids,
GABA, acetylcholine, norepinephrine, opi-
oid, and growth factor receptors. Pharma-
cological comparison ofthese receptors in
vivoand in slice preparations show identical
characteristics not only in activity but also
in cellular distribution. This is not always
the case fordissociated neurons.
Although slice cultures display a high
degree of neuronal differentiation, this
technique does not ensure that all cell types
survive or that all important properties such
as receptor sensitivity or neuronal connec-
tions are established. Although important
features ofthe characteristic cellular and tis-
sue organization ofthe original tissue are
retained, the multitude ofconnections from
various other brain regions is not repre-
sented. Loss ofafferent input to the slices
results in synaptic rearrangement within the
slice culture. The absence ofboth efferent
and afferent connections that would nor-
mally occur in vivo is a significant factor in
determining the types of questions that
could be addressedwith such a system. This
procedure demands from the experimenter
an understanding of the morphological
characteristics ofthe region examined.
Explant/slice cultures originate from
animals; although a number ofslices can be
obtained from any one animal, statistical
concern requires slices generated from
numerous animals. (i.e., animal= statistical
unit). Given the various maturation times
for each brain region, the optimal age to
obtain brain tissue will vary among the dif-
ferent brain regions, limiting the likelihood
ofcollecting various brain regions from any
one animal. Additionally, survival time
must be considered i.e., the slices must be
processed into culture within a defined
period oftime, usuallywithin 45 min.
HippocampalSlice Cultures. Preparations
are obtained from the brains of5- to 7-day-
old rodents. A 400-micron slice is placed
on aspeciallyprepared slide and cultured in
roller drums. An estimated number of 10
slices can be obtained from each animal.
After several weeks in vitro, the thick slices
will flatten to virtual monolayer thickness
thus allowing observation of individual
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neurons under phase contrast microscopy.
This flattening is due to a lateral migration
ofnerve cells that are located in the deeper
layered structures. This reorganization is
proposed to be due to a limited oxygen
supply at the deeper layers. Additionally,
any structures adjacent to the cut surface or
the severed afferent and efferent fibers
degenerate. With the hippocampal slice,
the reorganized three-dimensional struc-
ture retains the original hippocampal
cytoarchitectural relations (67). Morpho-
logical differentiation can be maintained
similar to in situ conditions for both the
pyramidal and granule cells. Synaptic orga-
nization can also be maintained; however,
aberrant supragranular projections are
often reported. Techniques using Golgi
impregnation and dye injections allow
evaluation ofmorphological differentiation
and dendritic arborization.
In slice culture, neurons and associated
cells can be maintained for relatively long
periods oftime, thus allowing for extending
periods ofexposure to assess toxicological
effects. Some researchers claim that slice cul-
tures can beviable for up to ayear; however,
the cellular phenotype will change with age.
Brain slices, especially the hippocampal
slice, have been used extensively for neuro-
biological studies and the approaches have
been adapted for utilization in neurotoxicity
evaluation. For example, the hippocampus
is vulnerable to excitotoxic agents such as
kainic acid, which causes aneuronal necrosis
ofthe pyramidal cells. The excitotoxic effect
ofkainic acid has also been demonstrated in
the hippocampal slice culture, with a selec-
tive vulnerability ofthe CA3 pyramidal cells
and no effect on the CAl neurons, granule
cells, and AChE-positive interneurons (68).
This ability to detect a selective effect is crit-
ical in assessing neurotoxicity because in
vivo, rarely are all cells of any one type
affected. The basis for neuronal selectivity
remains unknown. The hippocampal slice
preparation has also been used in assessing
the toxic response to bismuth. In agreement
with human data, acute exposure had no
effect (32). However, chronic application
produced morphological evidence ofpyra-
midal cell degeneration. The hippocampal
slice preparation has been used to study the
effects of organoalkyl metals such as
trimethyltin and triethyltin.
In situ, the hippocampus is critically
involved in the process oflong-term poten-
tiation as acomponent ofsynapticplasticity.
This process is of interest in many chemi-
cally induced alterations in neural function-
ing. The hippocampal slice preparation was
evaluated electrophysiologically after expo-
sure to the known hippocampal toxicant
trimethyltin and showed similar results to in
vivo effects (69); however, some important
differences were noted. These researchers
proposed the use ofthe hippocampal slice
culture preparation as a screen for neuro-
toxicity which would be able to differenti-
ate effects ofchemicals on excitatory and
inhibitory systems, mechanisms underlying
neuronal plasticity, and regional differences
in susceptibility to toxic insult. However,
such uses for this test system are well out-
side the criteria set for a screening test and
given the technical demands to confirm
the integrity ofthe slice and the complex-
ity of the hippocampal system, this test
system would probably be more useful in
addressing specific mechanism-based ques-
tions of both basic neurobiological and
neurotoxicological nature.
Other Brain Slices. Other brain regions
have been cultured successfully by the slice
technique including the cerebellum, cortex,
and the locus coeruleus. Like the hip-
pocampal slice, the dendritic arborization
ofneurons derived from the locus coeruleus
or cerebral cortex are similar to the in vivo
structure. The cultured cerebellar Purkinje
cells, however, form multipolar dendrites or
dendrites of reduced complexity as com-
pared to the in vivo state. Co-cultured slice
cultures have been used to establish an in
vitro analog of in vivo axonal connectivity
among various brain regions. The ability to
determine the success offiber infiltration
and connectivity is dependent upon the
selectivity ofimmunostaining for a parti-
cular cell type. For example, in co-cultures
oflocus coeruleus and cerebellar or hippo-
campal slices, the invading fibers from the
locus coeruleus can be visualized by
immunohistochemical staining with anti-
bodies to tyrosine hydroxylase. The co-cul-
ture technique has been used to study
trophic factor interactions, axonal target-
ing, and synaptic transmission. It offers a
unique method to examine such processes
under the influence ofvarious agents; how-
ever, the effectiveness of the model will
reflect the mechanistic question asked.
PRIMARY CULTURES. Suspension and
Reaggregate Cultures. Reaggregate cultures
have great utility for examining biochem-
ical end points where a large cell popula-
tion is needed. Brain tissue is dissociated
into a suspension of individual cells and
incubated under gyratory conditions to
form a confluent monocellular layer with
patterns ofcell alignment similar to those
seen in vivo. Within 1 hr, small cell clumps
(reaggregates) are formed. After 2 days
these reaggregates have a stable diameter of
0.15 to 0.8 mm depending on the dissocia-
tion technique and culture conditions
(70-72). Like explants/slices, a general dis-
advantage of reaggregates is the decreased
supply ofoxygen and other components of
the culture medium to the center of the
reaggregate. Dependent on the tissue from
which the cells were derived, several layers
can be discriminated with reaggregates
with patterns of cell alignment similar to
those seen in vivo (73-75). In addition,
some foci ofcells ofthe same cell type are
observed after some days in culture inner-
vating other parts ofthe reaggregates. The
cells undergo morphological differentiation
including synaptogenesis and myelination
(74,76,77). In a developmentally regulated
pattern, the cultures express cellular spe-
cific proteins for neurons and glia. Critical
to this technique are the age ofthe donor,
the nervous system site extracted, the cul-
ture conditions, and the dissociation proce-
dure used. Not only are these features
critical to the viability ofthe culture but
also to the degree ofcytoarchitectural devel-
opment. Reaggregate cultures can be main-
tained by rotation under continuous
incubation conditions using chemically
defined media for prolonged periods of
time (maximum reported >6 months) (72).
Thus, the cells can be used immediately in
suspension to assess acute biochemical
responses or used for future examination of
biological responses. Reaggregates have
been proposed for use in toxicological
studies (78,79).
DissociatedPrimary Cultures. The dissoci-
ated primary culture is the most widely used
in vitro system in neurobiology. Typically,
tissue is removed from the embryonic or
fetal animal and dissociated mechanically or
by proteolytic enzymes. The cells then are
washedandplaced in culturedishes. Usually,
within an hour living cells will adhere to the
culture dish substratum. Cells ofthe CNS
are anchorage dependent and those that do
not adhere usually die. The fraction ofcells
which adheres and survives varies greatly
with the type oftissue. The platingefficiency
is dependent on the dissociation technique,
the type ofsubstratum, the culture medium
composition, and the type of tissue. A
reduced initial survival rate may induce a
change in the cell type composition, possi-
bly resulting in an artificial enrichment or
depletion ofcertain cell types. After the ini-
tial selection ofcells surviving the dissocia-
tion process, there is a selection for cells
compatible with the culture environment.
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The presence and amount ofserum and
trophic factors, oxygen tension, the composi-
tion ofthe substratum, and seeding density
strongly affects the viability and differentia-
tion ofcultured cells (dedifferentiation,
transdifferentiation, differentiation inhibi-
tion, induction ofdifferentiation). With
CNS tissue, alterations in technical para-
meters such as age ofdonor, dissociation
techniques, seeding density, and medium
composition can greatly influence the
characteristics ofthe culture.
Neuronalprimary cultures. Much work
has focused on obtaining cultures repre-
sentative of neuronal populations in the
brain, spinal cord, and ganglion. For each
ofthese preparations, the age ofthe donor
is critical for successful culturing of each
cell type from different brain regions.
Therefore, one is forced to maintain a con-
sistency in donor age in order to generate a
culture preparation. The dissection tech-
niques and nutrient media are unique to
each level ofthe neuroaxis and are empiri-
cally derived (6,7). For example, prepara-
tions ofhippocampal neurons are derived
from fetal brain tissue where cortical and
cerebellar neurons can be derived from
postnatal brain tissue. Even within a brain
region such as the cerebellum, individual
cell types require distinct donor ages. e.g.,
cerebellar granule cells are isolated from
postnatal day 6 to 8 brains whereas success-
ful Purkinje cell cultures require isolation
from fetal tissue. Although dissociated cell
culture techniques have been successful for
numerous brain cell regions and cell types,
cultures ofdissociated peripheral neurons,
sympathetic ganglion cells, and dorsal root
ganglion cells have been a more recent
addition. This is apparently due to their
fastidiousness with respect to their culture
media. However, successful conditions
have been established and such cultures of
the peripheral neurons have been used
extensively to study problems ofnerve dif-
ferentiation and electrophysiology. As
previously mentioned, whether these cul-
tures will be reflective ofthe in vivo con-
dition is a question that is continually
asked. In many situations this is not the
case. For example, Davenport et al. (80)
were unable to detect in primary neuronal
cultures ofeither the cortex or the cerebel-
lum the critical in vivodistinction ofdiffer-
ential sensitivity to monohalomethanes
between cerebellar and cerebral cells.
Glialprimary cultures. A number of
techniques and media conditions exist for
the generation ofdissociated primary cell
cultures of nervous system glia cells.
Usually a mixed glial culture is derived
from rat or mouse cortex between birth and
postnatal day 2 (38). Between 6 and 18
pups contribute to each culture preparation
comprised ofthree phenotypically distinct
glial cells, the astrocyte, the oligodendro-
cyte, and the microglia. Based upon differ-
ential cell adhesion, each cell type can be
subcultured to a relatively enriched popula-
tion. Although much information is avail-
able on each individual cell type in culture,
only recently have the interactions among
the various glial cells been appreciated. In
addition, results previously obtained from
a pure culture of astrocytes must now be
reconsidered in light of new information
on the function and responsiveness of
other glial cells and techniques used to
assess culture purity.
Depending on the age ofthe donor, cell
cultures differ dramatically in the glial cell
composition, the maturation process, and
biochemical responsiveness. Therefore, it is
critical to any interpretation ofexperimen-
tal data that the donor age be maintained
within a well-characterized biological and
morphological window. For rodent cortical
astrocytes and oligodendroglia, this is
between birth and day 2 postnatal (38).
Individual glial cell cultures can be gener-
ated based upon differential attachment of
each cell type. Once a mixed glia culture
has been established, e.g., in approximately
2 weeks, culture flasks can be shaken (250
rpm) to dislodge both microglia (within 2
hr) and oligodendroglia (18 hr) from the
underlying astrocyte monolayer. A micro-
glia culture can be obtained from these
mixed glia cultures by plating ofthe media
removed after 2 hr ofshaking. Cells are
allowed to attach to tissue culture plates
over approximately 1 hr. The media is then
removed and replaced with fresh media.
After shaking, astrocytes can be subcultured
by enzymatic detachment, filtration, and an
initial plating period of 1 hr to remove any
remaining contaminating microglia.
Additional steps must be taken to ensure
removal of any contaminating microglia
from the oligodendroglia subculture. After
cellular enrichment, medium conditions are
manipulated with 1% fetal calfserum or
chemically defined medium to ensure
differentiation ofprogenitor cells to oligo-
dendroglia. The generation of enriched
subcultures depends upon a relatively large
numberofanimals.
The majority of experiments using
Schwann cell cultures have investigated the
normal interactions between Schwann cell
and axons. Three approaches have been
used to isolate Schwann cells for culture.
Fresh sciatic nerve tissue isolated from
2-day-old rat pups undergo enzymatic
digestion with trypsin and collagenase, fol-
lowed by trituration and plating for 24 hr.
These cultures initially contain both bipo-
lar spindle-shape Schwann cells and fibro-
blasts. The rapidly dividing fibroblasts are
removed by the addition ofthe antimitotic
agent cytosine arabinoside for 48 hr fol-
lowed by removal for 6 hr and readminis-
tration for 24 hr (81). Cells can be be used
for experimentation after being allowed to
recover for an additional 24 hr in normal
media. Typically, 0.8 x 106 cells/12 pups
can be obtained, with approximately 95%
characterized as Schwann cells. A similar
procedure can be used to isolate Schwann
cells from frozen neonatal sciatic nerves
(82). Sciatic nerves from 2-day-old rat
pups can be slow frozen in media, DMSO,
and fetal calfserum (50%) and stored in
liquid nitrogen. This method differs from
the fresh tissue procedure in that frozen
nerve cells require an additional 2 days to
recover from the initial dissociation. Thus,
this procedure requires a total of 7 days
from dissociation to final use rather than
the 5 days required when using fresh tissue.
One major advantage to the use offrozen
tissues is that tissue can be collected over
time and stored until a sufficient amount is
obtained for an adequate cultured cell
yield. Schwann cells from both prepara-
tions appear identical in morphology and
in their response to axonal membrane
mitogens. An immortalized Schwann cell
line has been produced and offers the
advantage ofrapidly generating extremely
large numbers of Schwann cells that are
genetically identical (83). These cells are
similar to primary Schwann cells in their
immunoreactivity to Ran-2 and glial fibril-
lary acidic protein antibodies and in their
ability to segregate individual neurites in
cultured dorsal root ganglia (83). When
plated on the artificial basement membrane
matrigel, the cells appear to react similarly
to primary cells; however, their prolifera-
tion rate is decreased and the cells take on a
spindle-shape morphology, suggesting a
termination ofproliferation and initiation
ofdifferentiation (84). Whether primary
cells or cell lines, Schwann cells are very
sensitive to the substratum and the serum
concentration. They grow best on laminin
or other extracellular matrix substratum
and they require high levels of serum
(10%). They do poorly in lowserum (1%),
especially in any studies examining a
response to chemical exposure.
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Data suggest that Schwann cell cultures
can be used to study the initial proliferative
responses and the transduction mechanisms
involved in the proliferative response of
Schwann cells to axonal membranes
(85-90). Schwann cell expression ofmyelin-
related proteins is exquisitely sensitive to
axonal contact. In culture Schwann cells do
not make a detectable amount of the
myelin-specific protein P0 (81). Early exper-
iments examining toxicant-induced alter-
ations in Schwann cell functioning focused
on the effects oflead due to the in vivo
effect ofademyelinative peripheral polyneu-
ropathy. Pleasure et al. (91) demonstrated a
lead-induced decrease in the rate ofcell pro-
liferation with no alteration in the ability to
differentiate. However, in many cases of
peripheral nerve toxicity, the chemical of
interest produces a characteristic demyelina-
tion in vivo. Although it is possible to estab-
lish a co-culture with axons in which
Schwann cells produce myelin, these proce-
dures are extremely difficult and the degree
ofmyelination is minimal, unlike the nor-
mal in vivo situation. While limited aspects
ofSchwann cell function can be examined
in vitroanyinterpretation ofdatawithin the
framework of in vivo toxicant-induced
peripheral nerve demyelination is limited if
not impossible.
CONTINUOUS CELL LINES. Continuous
cell lines are transformed cells derived from
neuroblastomas, gliomas, and pheochromo-
cytomas with a useful life span ofapproxi-
mately 50 divisions. Cell lines oflimited life
span often undergo crisis after which their
growth potential changes and their life span
becomes unlimited. These cell lines are
termed immortalized cell lines. The major
attributes ofcontinuous clonal cell lines are
homogeneity and the easewithwhich alarge
quantity ofcells can be grown. Features of
established cell lines indude the capacity to
undergo an unlimited number ofcell divi-
sions, altered cell and colony morphology,
lack oflocomotion, lack ofcontact inhibi-
tion, lack ofdensity-dependent inhibition
of cell multiplication, loss ofanchorage
dependence, and high fibrinolytic activity
(92). In addition, once the phenotype of
the cell line is established it does not
change. However, it has been observed
quite often that the cells will drift with
regard to physiological responsiveness with
increased passages.
Cell lines are available for a number of
donor species, but availability ofneural cell
lines is rather limited. Lines of cells exist
that are representative of neurons (neuro-
blastomas) and glia (oligodendrocytes,
Schwannoma, astrocytomas). Because of
the numerous limitations ofworking with
tumor-derived cells, cell lines devoid of
tumoral properties have been generated
with the use ofretroviral vectors for trans-
ferring oncogenes to glial or neuronal prog-
enitor cells in culture. With some rapidly
dividing cell types, such as glia and myo-
blasts, a large cell population can be derived
from the progeny ofa single cell. It is there-
fore possible to have clonal primary cul-
tures, which is the only way to assure that
all ofthe cells in the culture are phenotypi-
cally identical. However, clonal primary
cells are limited in the number oftimes that
they can divide. This limited life span of
cultured normal cells has been associated
with in vivo aging. Many ofthese cell lines
displayproperties oftheir normal cell coun-
terpart. For example, the v-myc immortal-
ized sympathoadrenal progenitor cell line,
MAH, differentiates into neurons upon
exposure to fibroblast growth factor.
Neuroblastoma C1300 cells can be induced
byserum modification to extend neurites.
One problem with the use ofclonal cell
lines is the limitation in the number ofcell
lines available that express well-character-
ized in vivo phenotypes. The derivation
from neoplastic tissue suggests an origin
which makes the cells abnormal and
detracts from their usefulness. However, it
needs to be mentioned that all cells acquire
abnormal characteristics when placed in a
tissue culture environment. Although con-
tinuous lines lack the type ofgrowth regu-
lation seen in vivo, the critical point for
experimental use is whether the cells
express the differentiated characteristic of
interest identical to those in vivo. Ifthey
do, information on the binding characteris-
tics of the test compound to the target
receptor or binding site molecule may be
studied as an important first step in the
toxicity. However, caution should be exer-
cised prior to using cell lines for toxicity
studies even ifthey express the differen-
tiated characteristic of interest. As the
genetic amenability and response to a test
compound may be dramatically changed in
cell lines as compared to the original pri-
mary cells, unforeseen cell line specific
effects may occur. Thus, the data may not
be applicable for direct extrapolation to the
in vivocondition.
One ofthe major limitations ofcontin-
uous cell lines is the difficulty in inhibiting
cell division experimentally to obtain a sta-
ble population ofdifferentiated cells. This
is in contrast to the in vivo situation where
the end cell in a differentiation sequence
usually does not divide. The cellular homo-
geneity ofcell lines may be appropriate for
the purpose ofstudying selectivity ofneuro-
toxicants in toxicological studies. This
homogeneity would limit the cellular inter-
actions and the cells would not be exposed
to the complex network ofmessages typical
for neuronal circuits. In many cases, differ-
entiation is induced by chemicals and drugs
by a mechanism that is not fully under-
stood. It is not known ifit is comparable to
the differentiation process that occurs in
vivo. In general, cell lines show much less
sensitivity to toxicants than primary cell
cultures. For example, the cholinergic cell
line NG-108-15 is much less sensitive to
AF64A than primary cells (93).
Genetic stability of any given pheno-
type is critical to the reproducibility of
experimental findings. Clonal cultures can
undergo variant selection that can be
explained somewhat in terms ofpoint muta-
tions, deletions, or chromosomal rearrange-
ments. Additional data suggest that cells are
able to respond in avarietyofways to strong
selective agents and that the frequency of
variant selection may reflect an interplay
between two or more independent mecha-
nisms. Examples of initial phenotypic
instability are donal liver cell lines that fre-
quently lose the ability to synthesize and
secrete albumin after a fewdozen passages in
culture, and skeletal muscle myoblasts that
cease to differentiate after a few transfers.
Examples ofphenotypic change have been
reported for PC-12 cells with increased
number ofpassages (94). It is likely that the
origin ofvariants in clonal cells can be
explained in terms of classic mutational
mechanisms orepigenetic phenomena.
Glioma cell lines. The C6 glioma cell
line was derived from a chemically induced
glioma in an adult rat (95). These cells pos-
sess many ofthe regulatory control mecha-
nisms and differentiated properties ofglial
cells. When dibutyryl cyclic AMP is added
to primary CNS glia cultures or to glial cell
lines, there is an increase in morphological
complexity which is reversible upon
removal (96). Chemicals which increase
intracellular cyclic AMP produce similar
morphological changes (97). Dibutyryl
cyclic AMP has been used extensively to
study the effects ofvarious factors on differ-
entiated glia cells (98). C6 cells have been
used in numerous studies both oftoxicity
and basic cellular mechanisms. This cell
line has been established as a model in
which several aspects ofhormonal action
previously observed in vivo or in primary
brain cell cultures can be studied (99). C6
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glioma cells have been used to study the
regulation and modulation ofmyelin spe-
cific genes (100-102). Based upon the in
vivo experimental studies and human case
reports suggesting that major target sites of
lead acetate are myelinating cells ofthe ner-
vous system, these cells have been used to
examine the toxicity oflead acetate. Results
suggest that lead has a selective inhibitory
effect on an oligodendroglial function
expressed in the C6 glial cell line. This was
demonstrated by a dose-dependent inhibi-
tion of the glucocorticoid induction of
soluble cytoplasmic GPDH at the level of
transcriptional processing. Since GPDH is
a specific biochemical marker for the
myelin-forming cells and oligodendrocytes
and is believed to be involved in myelina-
tion, the selective inhibitory effect oflead
on GPDH induction is consistent with the
in vivoobservations ofhypomyelination.
Neuroblastoma cell lines. Cell lines have
been established from both mouse and
human neuroblastomas which express sev-
eral neurotransmitter-synthesizing enzymes.
This feature makes them good candidates
for the study ofregulation ofgene expres-
sion and for the establishment of cDNA
libraries. The first neuroblastoma cell lines
were derived over 40 years ago. They form
homogenous populations, proliferate
rapidly in chemically defined media, extend
neuritic-like processes and contain several
neurotransmitter precursor molecules such
as tyrosine hydroxylase. When using neu-
roblastoma cells it is important, and at
times difficult, to distinguish between mor-
phologic differentiation and cytotoxicity
(103). In pesticide research, neuroblastoma
lines are used because of the presence of
the target enzymes AChE and NTE (104).
The NIE115 neuroblastoma, cloned from
the murine neuroblastoma C1300, has
been used to study features associated with
organophosphate-induced delayed neuropa-
thy (OPIDN) with an attempt to rank
NTE inhibition levels after exposure to var-
ious organophosphates (105-107). For
these reasons, it has been unofficially pro-
posed as a substitute for the Hen test that
the U.S. EPA Pesticide Registry uses to
detect organophosphorus pesticides capable
ofcausingneuropathy (OPIDN).
Human neuroblastoma cell lines are
similar to mouse or rat neuroblastoma cell
lines; they are generated from human tissue
and may offer species-specific responses to
neurotoxic agents. One such cell line is the
IMR32, which differentiates upon stimula-
tion with several drugs and expresses sev-
eral neuronal characteristics and functions
such as neurotransmitter synthesis and
storage, receptors, and ion channels. In
such cells, the specific neuronal end points
examined are associated with neurite out-
growth and expression ofneurotransmitter
receptors. General cytotoxicity is deter-
mined as an indicator ofneurotoxic speci-
ficity. Pharmacological experiments have
demonstrated that IMR32 cells express sur-
face nicotinic and muscarinic cholinergic
receptors and that classical pharmacological
dynamics are present at these receptor sites.
These cells have been used to examine the
toxicity ofvarious metals that target the
cholinergic system in vivo. SY5Y is a sub-
clone ofthe human neuroblastoma SK-N-
SH and has neurotoxic esterase activity
comparable to brain, thus allowing the
studyofOPIDN-inducing chemicals.
Pheochromocytoma cells. The PC-12
clonal cell line was established from a rat
pheochromocytoma (adrenal medullary
tumor) and has many properties in com-
mon with primary sympathetic neuron
and chromaffin cell cultures (94,108).
These cells can be induced to differentiate
in the presence ofNGF to resemble sym-
pathetic neurons, to extend neurites, in-
crease tyrosine hydroxylase (TH) activity,
and dedifferentiate with the removal of
such growth factors [for review see Fujita
et al. (109)]. The PC-12 line has been
used extensively to examine the mecha-
nisms underlying NGF response and nerve
differentiation. Depending on the condi-
tions, PC-12 cells synthesize AChE, acetyl-
choline, and choline acetyltransferase as
well as release dopamine, norepinephrine,
and acetylcholine. They contain sodium,
potassium, and calcium channels, and vari-
ous other membrane receptors including
receptors coupled to G-proteins. For these
reasons they have been used extensively to
examine the basic biologyofneurotransmit-
ter biosynthesis and secretion, neuronal
differentiation, calcium ionic flux, and sig-
nal transduction mechanisms. Theyprovide
a useful model for studying processes
associated with neuronal differentiation,
synthesis, storage, and release of neuro-
transmitters, function and regulation ofion
channels, and interactions ofcompounds
with membrane-bound receptors. In toxi-
cology, PC-12 cells have been used to eval-
uate chemical induced alterations in
calcium channels neurotransmitter release
and receptor, and by both biochemical and
physiological methods (110-113).
ADDITIONAL CULTURE SYSTEMS.
Microcarrier techniques have been devel-
oped to study different cell types in vitro
(114). These microcarriers have averylarge
surface-to-volume ratio and can be used to
obtain high yields ofcells from small culture
volumes. This system allows for mixtures of
cell types to be produced at any defined
ratio and as such offers an attractive model
for examining specific questions concerning
cell-cell interactions. Microcarrier tech-
niques have been applied to study fiber out-
growth, synaptogenesis, myelin formation in
neural cells, and metabolic interactions
between cells.
Transgenic mice carrying target con-
structs ofthepolyomalargeT or SV40 large
T gene, have been used to establish both
astroglial and neuronal cell lines. Recent
developments in cell fusion techniques have
allowed neuronal cells ofdefined origin to
be "immortalized" by fusion to a trans-
formed cell line. For example, the NG108-
15 hybridoma was developed by fusion of
the mouse neuroblastoma clone N18TG2
with the rat glioma clone C6BU1 using
Sendai virus (115). This hybridoma offers
the characteristics ofnerve fiber extension,
synapse formation, choline acetyltransferase
activity, and receptors for various neuro-
transmitters (116). The NSC-34 spinal
cord neuron x neuroblastoma hybrid cell
line has been used to evaluate chemicals that
have an in vivo site ofaction at the motor
neuron (117). These cells have been pro-
duced by fusion ofmotor neuron-enriched,
embryonic mouse spinal cord cells with
mouse N18TG2 neuroblastoma cells (117).
The cultures contain two populations of
cells: a) small, undifferentiated cells that
have the capacity to undergo cell division;
and b) larger, multinucleate cells that
express many properties ofmotor neurons.
These cells proliferate in culture, but also
express a number ofmotor neuronlike prop-
erties without the need to add inducing
agents like NGF to the culture medium.
Such processes include extension ofneurites;
generation ofaction potentials; expression of
neurofilament triplet proteins, neuron-
specific enolase and choline acetyltrans-
ferase; synthesis and storage ofacetylcholine,
induction ofacetylcholine receptor aggre-
gates on co-cultured myotubes; and expres-
sion ofa receptor for the neuromuscular
junction-specific basal lamina.
The NSC-34 cell responds to agents
that affect voltage-gated ion channels,
cytoskeletal organization, and some com-
ponents ofaxonal transport. Investigation
into the use ofthese cells as a test system
for neurotoxicity examined chemicals that
exert their neurotoxicity by altering specific
neuronal functions: action potential
Environmental Health Perspectives * Vol 106, Supplement 1 * February 1998 146IN VITROTECHNIQUES FOR THE ASSESSMENT OF NEUROTOXICITY
production, axonal transport, neurofilam-
ent organization, and neurotransmission
(117). The cytoskeletal proteins in NSC-34
cells are sensitive to 2,5-hexanedione in the
formation of intermediate filament aggre-
gates. The timing for such studies is criti-
cal-as the expression ofvimentin decreases
with differentiation, the sensitivity ofthese
filaments to aggregation by 2,5-hexane-
dione decreases (118). Chemical-induced
changes linked to axonal transport have
been examined only with sodium pyridine-
thione. In this case, retraction and focal
swelling ofprocesses was observed at only
the highest dose and may be a manifesta-
tion ofcytotoxicity rather than an alteration
in organelle transport. The cells detected
chemical-induced changes in voltage-gated
ion channels although there were quantita-
tive differences from primary motor neu-
rons. These cells do not form functional
synapses with cultured myotubes and there-
fore are not a test system for evaluating
synaptic transmission (117). Most interest-
ing is the fact that the NSC-34 cell does
not require chemical induction to express a
differentiated phenotype, providing an
advantage for cell biological evaluations.
However, the inability to prevent differenti-
ation is also a disadvantage in that the pop-
ulation ofcells most likely to differentiate is
gradually diminished with successive sub-
culture. Although fusion techniques can
create such hybrid cells, many ofthe neu-
ronal characteristics are lost from such
preparations after a certain number ofpas-
sages. Attempts have been made to transfect
primary cells with oncogenes but these cells
usuallyonly survive for a short time.
EndPoints ofNeurotoxicity
The approach used most often to discrimi-
nate between neurotoxicity and general toxi-
city is to examine specific end points unique
to nervous system function and compare the
exposure relationship between these end
points and other nonspecific end points that
would be ubiquitous to all eukaryotic cells.
Another approach has been to compare toxic
responses between neuronal and nonneu-
ronal cells. A number ofend points have
been proposed as simple and rapid methods
to assess chemical toxicity in vitro. Many end
points proposed to detect neurotoxicity
make the primary assumption that neurotox-
icants affect specific nervous system func-
tions. The following sections will review
various measurements ofbasal cell function-
ing and end points that may be unique to
the nervous system and target sites of
chemical perturbation.
BasalLevel ofCellFunctioning. Basal
level end points reflect generic cell function-
ing necessary for cell survival. Although
basal cell function assays are used as an
index ofcell lethality, these measurements
do not necessarily give an indication ofthe
type ofcell death. Measurements ofcell tox-
icity include evaluation ofmacromolecular
synthesis, lipoperoxidation and generation
of reactive oxygen species, indicators of
mitochondrial and lysosomal activity, loss of
ions or cofactors, induction ofapoptosis and
DNA integrity, energy regulation (oxida-
tive-reduction status), generic cell functions
(respiration, ion transport, and protein and
DNA turnover), cell-cell communication
via gap junction integrity, biosynthetic reac-
tions, transport processes, and specific
enzyme changes. Although these processes
can be used to assess the status ofthe cell,
basal cell function is often limited to assays
such as vital dye uptake, mitochondrial via-
bility assays, total cellular protein, or lactate
dehydrogenase release. Vital dye exclusion
assays are based on the ability ofcells with
damaged leaky membranes to allow the
entry ofstains such as Trypan Blue, or the
loss of intracellular stains such as neutral
red. Although thevital dye assays are used as
an index ofcell lethality, what they actually
measure is cell membrane permeability.
Since cells can survive some degree ofmem-
brane permeability, these measurements do
not necessarily equate with cell death. In
addition, methods such as Trypan blue
exclusion require a quantitation of cell
numbers containing the dye. The neutral
red uptake and 3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyltetrazolium (MTT) reduc-
tion assays have been widely used as
semispecific indices of aspects ofcellular
function (119). These indices can provide
measures of cytotoxic potential that are
more sensitive than vital dye exclusion. Any
microscopic quantitation can prove to be
problematic with cells forming clusters or
cells that have a flat morphology such as
astrocytes or fibroblasts. With fluorescent
dyes such as ethidium homodimer and pro-
pidium iodide also excluded from live cells,
a fluorescence-activated cell sorter can
count the number offluorescent cells auto-
matically. For this, however, the cells have
to be detached from the substratum and/or
have to be dissociated into single cells.
Another method is to measure total culture
fluorescence before and after destruction of
the cell membrane. As such assays require
washing to remove excess dye, cells that lose
adherence or disintegrate would be removed
from the final determination.
The cytosolic enzyme LDH has been
proposed to monitor toxicant exposures that
last for days or weeks. It is assumed that
over time the enzyme marker accumulates
in the medium and that a stable reading of
this accumulation should be available at the
end ofthe exposure. It must be noted that
LDH is not a stable enzyme and its half-life
can be influenced byother products released
by cells. In all cases, any measurement ofa
substance released by the cells into the
medium must be examined relative to the
total amount available for release. Therefore,
such studies would determine the amount
of the marker both in the medium and
inside ofthe cell and express the data as a
ratio of released/total marker. One must
consider other factors that may come into
play, especially in a mixed cellular culture,
such as a concomitant induction ofendoge-
nous substances. Such substances could de-
grade proteins in the medium and influence
any protein measurement ofleaky mem-
branes. Healthy cells uptake such substances
as radiolabelled proline, adenosine, and
chromium; elevated release can be a reliable
and easily monitored index oftoxicity. For
measurements of51Cr release, cells are pre-
loaded with 51Cr and the amount released
into the medium after toxicant exposure is
measured in a gamma counter. The relative
amount released as a fraction ofthe total
amount in the preparation is the measure of
cytotoxicity. All ofthese measures reflect the
permeability ofthe membrane and do not
directlyconfirm cell death.
Cytotoxicity and viability end points
provide information on the intrinsic toxicity
ofchemicals. They have limited ability, if
any, to predict neural-specific effects.
However, such end points must be included
to determine the health status of the cells
at the time ofprocess evaluation and possi-
bly to differentiate specific effects from
general cytotoxicity. In many cases a dis-
tinction is made based on the selectivity of
the endpoint examined. For example, dif-
ferentiated cell functions such as axonal
transport, synaptogenesis, myelination,
enzyme activities, and neurotransmitter
function could be examined for neurotoxi-
city. Characteristics of neurotoxicants
could include neurotransmitter-specific
accumulation, release, or metabolism by
the neural cells. The development ofearly
and cell-specific indicators of the reaction
of neuronal cells and astroglial cells to
injury will require examination ofneuronal
and glial-specific protein changes. It is
commonly acknowledged that given the
complexity ofthe nervous system, no single
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endpoint can encompass the range of
neurotoxic targets. A suggestions to over-
come this complexity has been to include a
variety ofmultiple end points. Again, given
the complexity of the nervous system, the
ability to select such multiple end points to
reflect the dynamics ofthe nervous system
is limited by our current minimal under-
standing of mechanisms associated with
neurotoxicity in vivo.
Target Sites ofNeurotoxicity. In the
attempt to develop in vitro systems to eval-
uate the neurotoxic potential ofchemicals,
one should identify in vivo target sites or
processes, understanding the biological
details associated with the in vivo process
and the types ofperturbations that can be
induced on any one particular target by
various chemicals. A model system cannot
be developed in isolation. Without an
understanding of the basic biology, the
points at which the basic process can be
altered, and the types of injury, a model
system with any usefulness or meaning
cannot be developed. In fact, the develop-
ment and use of an inappropriate model,
whether in vivo or in vitro, can cause dam-
age by providing potentially biologically
invalid experimental data. A number of
biological processes that are target sites for
neurotoxicants in vivo are easily examined
with in vitro systems. The following exam-
ples will attempt to address some ofthese
proposed processes.
STRUCTURAL. Morphological end
points including effects on the cell body,
axons and dendrites, can be crucial in the
assessment ofchemical-induced alterations
in target cell populations as different mor-
phologic patterns of chemically induced
damage can be observed in vitro (120).
Morphologic lesions, however, have re-
ceived onlylimited attention as in vitroend
points ofneurotoxicity. The interpretation
of altered morphology in neural cell cul-
tures is hampered by the paucity of
descriptions regarding normal cytology, the
range ofpossible cellular lesions, and the
types ofpossible artifacts which mayoccur.
Neurons exposed to substances in
culture often develop structurally abnormal
neurites. A common phenomenon is bead-
ing, which is the formation of gross
organelle-filled dilations spaced at intervals
along the neurite. Beading occurs in cells
exposed to colchicine (121), acrylamide
(122), or ethylene oxide (123). Mor-
phological alterations can be seen in astro-
cyte cultures in response to chemical
agents. For example, trimethyltin alters
astrocyte morphology, as demonstrated by
a retraction ofprocesses and a central focus
and increased size of the cell body (37).
Microglia may be induced to differentiate
into an ameboid form and initiate phago-
cytosis (124,37). All neural cells may be
induced to change morphological pheno-
type in the retraction ofcellular processes
along the substratum.
Neurite Outgrowth. Neurite extension is
a fundamental property ofneuronal cells in
vitroand depends upon a number ofcritical
cellular processes such as axonal transport.
Although time-consuming, quantitation of
neurite outgrowth is a relatively easy task.
In addition, neurite outgrowth can be
determined by the measurement ofneurite-
specific structural elements, for example,
microtubule-associated proteins, neurofila-
ment proteins. The ability of biological
factors, pharmaceutical agents, or environ-
mental and industrial compounds to inter-
fere with neurite outgrowth is often used
to screen activity of new substances. In
many cases, one examines a substance's
ability to stop ongoing normal outgrowth
or the induction ofcells to retract neuritic
processes. Assays for neurite-promoting
factor, neuronotrophic factors, and glial
maturation factors are often used to assess
effects ofexogenous substances on develop-
mental processes. It has been proposed that
one may examine a compound's ability to
block biologically induced neurite out-
growth as can be seen in nerve growth fac-
tor-treated cells (125,126). However, this
approach is limited because the inhibition
ofinduced outgrowth may be due to indi-
rect effects resulting from the absence or
modification ofcertain enzymes or struc-
tural elements rather than from an effect
on the cells' ability to generate neuritic
processes. Although this approach may
offer information ofscientific interest, it
may not address the issue ofa direct effect
ofa chemical on neurite outgrowth.
Myelin. One major interaction between
neurons and glia that results in a structural
component of the nervous system is the
process of myelination. There are a num-
ber of disease processes and compounds
that will selectively alter myelin whether as
a hypomyelination, a dysmyelination, or a
demyelination [for review see Quarles et
al. (127) and Morell (128)]. Myelination
is specifically altered by triethyltin and
hexachlorophene, by developmental expo-
sure to inorganic lead, and by undernutri-
tion. In vivo research efforts in this area
range from morphological examination of
myelinated tracts and biochemical evalua-
tion ofmyelin proteins, to examination of
alterations in the regulation of myelin-
specific genes.
PERIPHERAL NERVE MYELIN. Because of
availability ofperipheral nerve tissue, much
of the work on processes of myelination
both in vivo and in vitro has focused on the
myelination ofthe sciatic nerve by Schwann
cells. The difficulties in culturing Schwann
cells are similar to other primary neural
cultures except for those associated with
myelination in culture. Stimulating the cell
to myelinate an axon is a very complicated
task that has been accomplished by only a
few laboratories engaged in mechanism-
based research. Even in these cases, the
number ofmyelin lamellae (wrappings) is
limited-a significant difference from the
in vivo condition. In vivo once Schwann
cells are in their final location on the axon,
they stop dividing and begin to elaborate
myelin around the nerve (129). The pres-
ence of myelin along the axon serves to
increase the velocity ofsignal conduction
along the nerve and reduces the energy
requirement for conducting the impulse.
In vivo Schwann cells make galactocer-
ebroside and the myelin-specific protein PO
after they have migrated down the nerves,
ceased dividing, and are developmentally
committed to myelination (130,131).
When they are cultured in the absence of
nerve, they initially contain galactocerebro-
side and P0, but the number ofcells con-
taining these molecules declines with a
half-life between 2 to 3 days. Given an
increase in cell number, this decrease is not
due to cell loss but rather a progressive loss
ofantigens. Much research effort has been
directed toward developing a model system
for myelination to understand its basic
underlying requirements. After 15 to 20
years work, we now know more about the
interactions between the myelinating cell
of the peripheral nervous system and its
environment. However, the culture system
is avery demanding system that has to date
only been applicable to mechanistic-based
research and is beyond the demands of a
screening test for neurotoxicity.
CENTRAL NERVOUS SYSTEM MYELIN.
Efforts to develop a system to examine
CNS myelination by oligodendrocytes
have a much shorter and complicated his-
tory. For example, unlike the PNS where
the relationship between Schwann cell and
axon is 1 to 1, the relationship between
oligodendrocytes is 1 to 40 separate nerve
fibers. In addition, not all Schwann cells
and oligodendrocytes produce a myelin
sheath. One model recently adapted to
examine CNS myelination is the cerebellar
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slice culture with a modification ofsubstra-
tum attachment rather than a roller bottle
method (132). It is still too early to deter-
mine whether this model will offer a
method to evaluate toxicant-induced alter-
ations in myelin. A model system to evalu-
ate both the process of myelination and
structural myelin wrappings would be
beneficial in understanding the action of
neurotoxicants that selectively target
myelin. However, critical in vivo target
sites for neurotoxicants are absent, i.e.,
multiple lamella and nodes of Ranvier
(spaces along the axon between each cell's
myelin wrapping). For example, triethyltin
and hexachlorophene both produce alter-
ations in myelin as evidenced by a splitting
ofthe intraperiod line (the space between
myelin lamellae) (133). Without multiple
wrappings a similar effect could not be
seen in vitro. Chemicals that produce
hypomyelination have a better chance of
being detected. However, in many ofthese
cases, such as in the developing nervous
system after lead exposure, the myelin that
is produced is normal in protein and lipid
content; there are just fewer lamellae and
thus less myelin (134,135). In vivo efforts
suggest that the perturbation is on the
myelin sheath and not a direct effect upon
the myelinating cell. This also would limit
the usefulness of a culture system that is
restricted to the cell body and to very little
ifanyplasmalemma in the form ofmyelin.
Although chemicals and disease processes
have been classified as primary demyelin-
ating agents, this classification system is
based upon a morphological criteria (136).
It does not take into account the role of
dynamic signaling interactions between the
myelin sheath and its underlying axon.
Whether the resulting pathology in the
myelin sheath is due to a direct effect on
myelin orthe myelinating cell or in response
to a perturbation in the underlying axon is
still a major question in whole animal mod-
els [for review ofneuropathies see Pleasure
(137)]. Additional yet critical players to the
morphological end product seen in vivo are
both the resident and the infiltrating
macrophages, which have the role ofstrip-
ping myelin from the axon and removing it
from the nerve area. Any in vitro model sys-
tem designed to determine effect ofa toxi-
cant on myelin would need to include all of
the known in vivoactive participants.
Existing in vitro systems allow exami-
nation ofthe signaling mechanisms linked
to initiation ofmyelination in the develop-
ing organism. However, given the diffi-
culty ofthe culture, such efforts should be
limited to well-defined, focused questions
aimed toward understanding the mecha-
nisms associated with perturbations to
developing myelinating cells. Efforts have
been made to develop an in vitro system to
model the vulnerability ofthe myelin genes
in the developing brain. Using mixed glial
cultures to preserve the temporal specificity
ofthe myelin gene expression, Royland and
co-workers (138) developed a system to
examine the effects ofnutritional depriva-
tion on myelin gene expression. When the
mixed glial cultures were maintained in
defined medium, myelin genes responded
to various manipulations such as alterations
in glucose concentrations. The cultures can
be further manipulated to produce cultures
ofpurified oligodendroglia, allowing for
more detailed examination ofthe mecha-
nisms associated with alterations in the
expression ofspecific myelin genes during
development. These cell culture systems
preserve the in vivo mechanisms ofactiva-
tion and upregulation ofmyelin genes criti-
cal for myelin development in vivo. Thus
the primary cultures allow for further exam-
ination oftoxicant-induced alterations in
myelination at the in vitro level and can
provide an additional experimental system
for studies of normal and abnormal gene
expression during development of the
brain. Aggregating cell cultures also provide
a useful system for biochemical and mor-
phological analysis of myelin and the
process ofmyelination and remyelination
(75,139-141). The morphological char-
acteristics in reaggregates are similar to
those in vivo, and myelin protein can be
isolated in sufficient quantities for bio-
chemical analysis. In addition, the yield of
the myelin-associated enzyme CNP and the
myelin protein composition is similar
between 30-day aggregate cultures and
adult rat brain (75).
FUNCTIONAL END POINTS OF NEURO-
TOXICITY. Axonal transport. Axonal trans-
port involves mechanisms similar to those
that all eukaryotic cells use to transport
materials from their sites of synthesis to
their sites of utilization and subsequent
sites of degradation. Alterations in this
process have broad implications for the
biological functioning of the organism
(142). A key question surrounding toxi-
cant-induced alterations in axonal trans-
port deals with whether the effect occurs
by direct or indirect mechanisms. A toxi-
cant can produce an effect on transport via
several mechanisms. It might interact with
a specific step in the mechanism ofaxonal
transport, directly affect the movement ofa
specific transport component without
altering transport per se, or alter the spatial
arrangement or production ofaxonal com-
ponents. Additionally, an effect might be
due to a more general biochemical disrup-
tion such as energy metabolism. The
majority of approaches used to examine
toxicant-induced alterations in axonal
transport have involved whole animals. Use
ofin vitrotechniques are now possible with
the establishment of the video-enhanced
contrast differential interference contrast
microscopy (VEC-DIC) methodology to
examine organelle movement along the
axon. The NIEl 15 murine neuroblastoma
cell line has been used to study pertur-
bations ofdifferentiation and axonal trans-
port (143-145). When the cells are
exposed to serum-free medium, they extend
large, stable neurites that are well suited to
analysis of intraaxonal movement of
organelles by VEC-DIC. Axonal transport
is determined by the number oforganelles
traversing a line perpendicular to the long
axis ofthe neurite; velocity is determined
by following individual organelles moving
along the neurite. This method has been
successful in detecting a significant reduc-
tion in bidirectional organelle flux induced
by vinblastine, an antimicrotubule drug
that impairs fast axonal transport in vivo
(143). Examination ofacrylamide, a neu-
rotoxicant that affects aspects of axonal
transport, showed a toxicity to differentiat-
ing neuroblastoma, but organelle move-
ment remained unimpaired. Comparison
with in vivo results raises the possibility
that rapid transport ofradioactive markers
could be altered without impairment of
vesicular traffic and lends support to the
observation that a subset of axons or
organelles is impaired byacrylamide (146).
These types ofdefects would not be readily
apparent using video microscopy if the
remaining organelles moved normally.
Therefore, such an in vitro system would
be limited to detecting perturbations that
affected all populations of axons or neu-
rites. This would be inconsistent with the
in vivo observations ofdifferential vulnera-
bility ofsensory or motor nerves to various
neurotoxicants. When these cells were
examined for their ability to detect the tox-
icity of acrylamide, no alterations in cell
morphology were seen until 2 weeks after
exposure to 25 pg/ml acrylamide. In the
exposed state, the growth cone on the lead-
ing edge of the outgrowth process was
defective and neurite swellings were noted
(147). Similar alterations in growth cone
integrity have been reported in N1E1 15
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cultures, chick clonal root ganglia cultures,
and chick spinal ganglia. Walum et al.
(122) showed that acrylamide exposure of
NIE115 cells produced neurite swellings
initially in the distal regions followed by
progression to the proximal portion. This is
similar to the distal dying-back axonopathy
observed in vivo following acrylamide expo-
sure. The level ofsensitivity ofthe cells was
determined with comparison ofeight cell
lines (neuroblastoma 41A3, neuroblastoma
N18, neuroblastoma N1El1 5, neuroblas-
toma x glioma hybrid NG108CC15,
glioma 13BMG, glioma C6, fibroblast
RLF, and fibroblast RMC). Of all these
cells, the NiE15 and NG108CC15 cells,
which are considered the most differ-
entiated ofthe neuronal cells tested, were
found to be most sensitive based on growth
characteristics and morphology.
Electrophysiological indices. Receptor and
ion channel expression can be studied in
vitro using electrophysiological recording,
although specific subtypes are best charac-
terized by single-channel recording. Such
detailed recording requires cell membranes
free from debris, which may be technically
difficult to achieve with organotypic or
explant cultures. In addition, synaptic
function and spontaneous activity in neu-
ronal networks can be readily monitored in
any system sufficiently complex to show
such activity. The net result ofcomplex
functional relationships may be evaluated
by relatively simple electrophysiological
techniques such as paired pulse inhibition
and long-term potentiation.
Blood-Brain Barrier. The blood-brain
barrier (BBB) both protects and nurtures
the brain (26,148). The endothelial cells in
brain microvessels are sealed together by
tight junctions and this cuff restricts the
passage ofmost polar and organic mole-
cules from the bloodstream to interstitial
fluid of the brain (149). Molecules pass
through the BBB by the aid ofprotein and
amino acid transport enzymes and carriers
such as y-glutamyl transpeptidase (GGTP),
alkaline phosphates, and glucose trans-
ported enzyme (GLUT-1) (150-152).
These endothelial cells ofthe BBB are phys-
ically in contact with astrocytes that influ-
ence many of their functions (153-155).
The astrocytes regulate the rigidity ofthe
tightjunctions, thus producing ahigherelec-
trical resistance across the cells. They can
enhance avariety ofenzyme activities such as
GGTP, an amino acid carrier, and regulate
the expression ofGLUT-1 protein. Thus,
the BBB can be disrupted either by damag-
ing the endothelial cell or by interfering in
the interdependency of astrocyte and
endothelial cells.
Although it has been clearly demon-
strated that toxicity is dependent on the
sensitivity and developmental stage oftarget
cells, concentration oftest compound, and
duration ofexposure, it has been proposed
that any chemical that passes the BBB is
neurotoxic (156). Since many chemicals
gain access to the brain parenchyma by dis-
rupting the BBB in vivo (157-162)
attempts have been made within in vitro
neurobiology to develop a model test sys-
tem. Questions concerning the BBB have
focused primarily on the use of isolated
microvessels prepared from bovine and
rodent tissues (26,153). One recently
developed system (163) is a co-culture ofa
bovine aortic endothelial cell line (or a rat
brain endothelial cells) with rat brain astro-
cytes (or C6 rat glioma cells) in a tridimen-
sional hollow-fiber culturing apparatus.
The system is maintained under pulsatile
flow conditions to mimic intraluminal
blood flow and to allow for chemical deliv-
ery. One cell line that has been proposed as
a model test system for the BBB is the
Madin-Darby canine kidney cell line. This
line displays a variety of functional and
enzymatic similarities to endothelial cells of
the BBB including electrical resistance,
tight junctions, and glucose transporter
enzymes, offering a number ofpotential
target sites for examination.
Signal Transduction Mechanisms.
CALCIUM HOMEOSTASIS. The normal func-
tioning ofthe neural cell is critically depen-
dent on the intracellular distribution of
calcium with cytosolic-free calcium func-
tioning as the critical pool for regulation of
intracellular events (164,165). The viabil-
ity of the cell can be affected when the
mechanisms of calcium homeostasis fail
(166-168). Ifthis highly synchronous and
coordinated process fails, there is an
increase in cytosolic-free calcium, which
can activate a number ofintracellular reac-
tions. Such reactions include the release of
neurotransmitter, phosphorylation ofpro-
teins, and protease activity (167,169-171).
Intracellular calcium also plays a role in the
control of neuronal growth and associated
growth cone activity. Many neurotoxic
agents with diverse mechanisms have been
reported to perturb intracellular calcium.
Included in these active chemicals are
methyl mercury, chlordecone, triethyl lead
(172-174), cyanide (175), pyrethroids
(176,177), methyl mercury, (168,175),
PCB congeners (178,179), and aluminum
(180-182).
NEUROTRANSMITTERS AND HORMONES.
Numerous culture systems have been
developed to address specific biological
questions with regard to nervous system
cellular induction of or responsiveness to
neurotransmitters or hormones. With
regard to neurotransmitter synthesis, clones
fall into four subsets: cholinergic; adrener-
gic, both cholinergic and adrenergic, and
neither neurotransmitter. All four subsets
synthesize and secrete large amounts of
AChE into the culture medium. Synthesis
ofboth catecholamines and acetylcholine
(ACh) tends to increase with morpho-
logical differentiation ofthe cells, although
there is no evidence of an exogenous
induction ofmorphological differentiation
producing either an increase or decrease in
neurotransmitter synthesis. The first donal
cell lines established in culture were
derived from C1300 mouse neuroblas-
toma. Given that this tumor had been pas-
saged for 30 years prior to growing in
culture, and that cell lines derived from
mouse tumors generally have very unstable
karyotypes, the hundreds ofclones isolated
from the original tumor have widely differ-
ent characteristics. Neurotransmitter syn-
thesis in C1300 clones is limited largely to
ACh and/or catecholamines due to the ori-
gin from cells ofthe neural crest. Cell lines
derived from human neuroblastomas also
synthesize predominantly ACh and/or cat-
echolamines (183).
Although the numerous mouse-derived
neuroblastoma cell lines available could offer
a culture system to examine alterations in
ACh or catecholamines, they offer very little
in other neurotransmitter systems. Rat clonal
cell lines offer increased diversity ofneuro-
transmitter systems. These cells make pri-
marily the inhibitory neurotransmitter
GABA acid, with a limited number ofcells
making small amounts ofACh and cate-
cholamines (184). Additional work by
Kimes et al. (185) demonstrated that sub-
clones were able to synthesize two or more
neurotransmitters, confirming that individ-
ual CNS cells, like those from the neural
crest, are able to make multiple neurotrans-
mitters. The clonal PC-12 cell line also has
the ability to synthesize both ACh and
norepinephrine (186). Data on polychlori-
nated biphenyls suggest an effect on cate-
cholamine metabolism in PC-12 cells similar
to CNS dopamine metabolism. This model
has been continued to examine the structure-
activity relationships among PCBs and
catecholamine metabolism. Another group
ofcultured cells able to synthesize multiple
neurotransmitters is the sympathetic
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ganglia. Dissociated sympathetic cervical
ganglia cells from newborn rats are able to
synthesize both ACh and catecholamines
(187-190).
Cell cultures represent an excellent
system in which to study trophic influences
ofgrowth factors and other compounds, as
the cholinergic neurons are easily assessable
for manipulation and observation. For
example, cultures ofdissociated cells from
the septal area offetal rat brains have been
used to study the effects ofNGF, thyroid
hormones, and gangliosides on septal
cholinergic neurons (191). Isolated adrenal
medullary chromaffin cells cultured in
defined medium are useful for studying the
regulation of tyrosine hydroxylase,
dopamine ,1-hydroxylase and phenyletha-
nolamine-N-methyltransferase, the key
enzymes in catecholamine biosynthesis [for
reviews see Furshpan et al. (189) and
Bunge et al. (192)]. This culture prepara-
tion usually require a retrograde perfusion
ofthe intact bovine adrenal gland with col-
lagenase, followed by separation ofmedulla
from cortex, and enzymatic and mechanical
dissociation ofmedullary tissue (193). The
ability to induce ACh synthesis is signifi-
cantly decreased with increased age ofthe
animal from which cells are obtained (188).
The avian ciliary ganglion represents
the most studied model ofa selected popu-
lation ofcholinergic cells in the peripheral
nervous system (194). The development of
cholinergic enzymes, the effect ofdenerva-
tion, and the effects ofaging on ganglia-
have been reported (195,196). The avian
system has several advantages. Its develop-
mental and aging process is well character-
ized; its size and location make it easy to
dissect; it is comprised ofa relatively large
and homogeneous cell population and it
can be studied both in vivo and in vitro. In
the chick, the ciliary ganglion is located 3
to 4 mm from the eye, deep in the orbit,
on the branch of the occulomotor nerve
that innervates the oblique muscles ofthe
eyeball. In addition to the branch of the
occulomotor nerve, ciliary nerves and
choroid nerves emerge from the ganglion,
providing innervation to the oblique mus-
cles of the eyeball, smooth muscles, and
striated muscles ofthe iris.
Based on immunocytochemical detec-
tion of TH and serotonin (5-HT), tech-
niques have been developed for dissection
of monoamine nuclei from embryonic
brain tissue for dissociated cell cultures,
explant cultures, or transplant cultures.
Although regions containing TH or 5-HT
immunoreactive cells can be delineated as
early as embryonic day 12 (E12), it is very
difficult to free the neural tube from the
surrounding tissue without damage. The
earliest stage allowing for dissection is E13.
With increasing age, the dissection becomes
easier. However, the yield ofviable cells
decreases rapidly and only one ganglion can
be obtained per animal. Thus, the optimal
time for tissue collection is E13 or E14
(197). Whitaker-Azmitia and Azmitia
(198) reported effects ofvarious serotoner-
gic drugs, drugs ofabuse, and other thera-
peutic agents including antidepressants on a
preparation ofdissociated primary cells
from midbrain regions rich in serotonin
neurons. One striking aspect of the data
was the variability in the results for any
given substance such that the results of
uptake ofradiolabeled serotonin were pre-
sented as qualitative changes rather than a
quantitative measurement. Factors con-
tributing to this variabilitywere time in cul-
ture, plating density, and presence of
steroids or glucose in the media. Based on
the effects ofamphetamine on brain cate-
cholamine function, NG108-15 neuroblas-
toma-glioma cells were used to study the
involvement of the serotonergic neuro-
transmitter system in toxicity induced by
amphetamine and its various derivatives.
[3H]d-Amphetamine uptake and cell viabil-
ity demonstrated a parallel dose-related
decrease after exposure to amphetamine
and its various derivatives (199). Cell death
as determined by these two measurements
could not be blocked by the specific sero-
tonin uptake inhibitor paroxetine, which at
higher doses was also toxic to the cells. The
ability ofthe cells to uptake amphetamine
and to show a differential pattern ofviabil-
ity response to various derivatives supported
the use ofthis culture system to screen for
the neurotoxic effects of drugs of abuse.
However, caution is necessary prior to any
widespread use ofthis approach, as the sys-
tem was unable to detect any differences
between the d- and 1-isoforms of am-
phetamine which in vivohave distinctly dif-
ferent effects on the nervous system: the
1-isoform has psychoactive properties and
the d-isoform lacks such activity.
The sexually dimorphic nucleus ofthe
preoptic area is an example ofa morpho-
logical gender difference in the rat hypo-
thalamus and has been a valuable model
for the study ofneural, cellular, and molec-
ular mechanisms bywhich gonadal steroids
influence the nervous system. The nucleus
is composed ofa heterogeneous population
ofneurons situated in the medial preoptic
area ofthe brain. The nucleus receives and
projects to numerous regions within the
limbic system, including connections to
most hypothalamic nuclei, and various
nuclei within the brain stem (200). This
system offers awealth ofcharacterization on
the effects ofsteroids, the developmental
critical period for steroid action and identi-
fied markers for neurons ofthe nucleus. It
has been used as a model for the study of
hormonal regulation ofgene action, which
can influence survival, differentiation, and
expression ofneuropeptides and receptors.
This system may offer a model to examine
the effects ofvarious estrogenic-like com-
pounds currently of concern for develop-
mental neurotoxicity. Unfortunately, only
one tissue punch per region can be
obtained for culture from either adult or
developing animals.
For the study of fully differentiated
neurons, methods have been developed to
isolate neurons from the mature mam-
malian brain. Usually, such methods are
used to isolate neurons for electrophysio-
logical measurements and not for culture.
It is possible to isolate neurons from small
circumscribed regions of the brain which
preserve dendritic structure, thus allowing
identification of morphological class.
Neurons can be isolated with intact synap-
tic boutons exhibiting spontaneous release
ofexcitatory and inhibitory neurotransmit-
ters (201). The procedure yields approxi-
mately 10 to 20% ofthe original cells and
would allow for investigation of specific
neurotransmitter-containing neurons.
REACTIVE CHANGES. Reactive changes
can be useful end points oftoxicity as they
can be used to determine threshold concen-
trations oftoxicity or to identify sensitive
systems prior to more mechanistic analysis.
GFAP is widely used as a marker of toxi-
cant-induced astroglial reaction in vivo and
has also shown value in vitro (202). GFAP
levels can be increased in the earlystages ofa
response, whereas a decrease is seen with
increasing cytotoxicity (203). Such biphasic
reactions are common and can lead to prob-
lems in interpretation ofresults. Inhibition
ofthe reduction of MTT has been widely
used as a measure ofimpaired mitochon-
drial or cytoplasmic reduction capacity, but
many agents produce a reactive stimulation
ofMTT reduction at low doses, followed by
a decrease at higher, cytotoxic doses (204).
Biphasic responses are also seen in a time-
dependent manner. The astrocytic toxin
dinitrobenzene decreases the glutathione
content of primary astrocytic cultures
within 2 hr while at subcytotoxic concen-
trations a larger reactive increase is seen by
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24 hr (205). Therefore, both time and con-
centration dependency must be established
before data interpretation is possible.
Even within common neurotoxic end
points, there is considerable variation
between chemicals that target a specific
process. Current information on sites of
action ofknown neurotoxicants can be help-
ful in determining the types oftarget sites to
examine. However, such information can be
misleading in that it offers the impression
that one would be able to determine the
potential for neurotoxicity in new and
untested chemicals using only current infor-
mation. Although this may be the case, the
techniques to evaluate these target sites are
sophisticated and require not only technical
training but also a biological understanding
ofthe system in order to conduct meaning-
ful scientific investigation, even at a prelimi-
nary level. In neurotoxicology, difficulty
arises when attempting to determine which
target sites should be used to evaluate neuro-
toxicity ofachemical with unknown biolog-
ical properties. Attempts to distinguish
between chemicals that produce cytotoxicity
versus a selective neurotoxicity in any cul-
ture system is hindered by the identification
ofa suitable global end point for neurotoxi-
city that can be examined within the culture
system ofinterest. With current advances in
cell biology and neurosciences, additional
elements ofcell processing are being identi-
fied which may allow for a limited number
ofcommon mechanisms ofcellular dysfunc-
tion to be identified. Until that time, efforts
to understand how neurotoxicants exert an
adverse influence on the various cells ofthe
nervous system will continue, based upon
current knowledge ofneurobiological func-
tioning, in vivo analyses, previously identi-
fied sites ofaction for numerous chemical
substances, and agreat deal ofhardwork.
QuantitativeAnalysis
The usefulness of an experimental model,
whether in vivo or in vitro, can be assessed
from many factors such as reproducibility,
sensitivity and speciflcity, or other mea-
sures which indicate how well the simpli-
fied system describes the biological process
in qualitative and quantitative terms. The
result ofsuch assessment is predictability.
What is frequently implied in toxicology is
that the ultimate objective of the model
experiment is to predict an effect in man.
Validation should be done byanalyzing the
biomechanisms at work in the model
system and comparing them with the
much more complex inner workings ofthe
whole organism. Usually the scope ofsuch
a comparison is limited. Therefore, we are
forced to limit the validation process to a
comparison ofthe outcome ofthe model
experiments with the results ofa compara-
ble challenge of the particular biological
system. Within the context oftest develop-
ment and acceptance, theword "validation"
has two definitions. One refers to the vali-
dation ofthe test in that it addresses such
issues as robustness and reproducibility
within laboratories, repeatability between
laboratories, standardization ofprotocols,
and decision-making criteria. All of these
factors are independent of the biological
relevance ofthe test.
The other definition refers to the valida-
tion ofthe end point. In this context, one
determines whether the test can measure or
predict what it is designed to measure, and
whether the end point is mechanistically
related to the effect ofinterest, including
criteria for interpretation of results. Some
models may be biologically useful but not
predictive. In this process one would need
to use analogs that are active and inactive
with respect to process, and examine effects
in context ofgeneral toxicity.
Because multiple samples can be gener-
ated from any one specific source, whether
a primary culture, cell line, or brain slice, it
is critical that each distinct preparation be
considered as the statistical unit (i.e., n for
statistical analysis). For example, even
though a number of brain slices can be
obtained from any given animal, the source
remains one animal and the animal
remains the statististical unit. The same is
true for a primary culture requiring a
pooled number ofanimals. The individu-
ally plated wells all represent one prepara-
tion, an n of 1. Within such preparations,
it is usually considered good experimental
protocol to assay each component of the
evaluation in triplicate. Such procedures
are standard in most biochemical assays.
The description ofa dose-response curve
obtained from in vitro experiments is gener-
ally based on a linear regression analysis,
plotting the logarithm ofthe dose on the
horizontal axis and the response on theverti-
cal axis. Although this method allows for cal-
culation ofan effective dose, it does not
allow for examination ofthe slope of the
dose-response curve. Each ofthese values is
important and can be manipulated by the
choice ofdata points. Such linear regression
analysis can not describe complex dose-
response curves such as those showing a
biphasic response. Forareviewofmathemat-
ical approaches to determine dose-response




Goldberg and others have suggested that
development of in vitro test models should
progress from the empirical to the more
defined (206-209). The questions are ini-
tially unfocused and the methodologies
heuristic. The subsequent in vitro models
are designed to specific in vivo targets and
incorporate mechanistically based end
points. Scala (210) proposed a three-phase
validation of in vitro models, with each
stage addressing a different degree ofinter-
pretability and reliability. In this approach,
in vitro models are initially established with
mechanistic end points incorporated. A
limited number of chemicals known to
target that mechanism are first tested.
Chemical selection for this initial stage is
used to define the relevant end points and
as a quality control standard. For example,
cell lines or primary cells that contain a tar-
get enzyme (i.e., AChE, NTE) for many
pesticides could be used to develop an in
vitrosystem to assess a specific process iden-
tified in vivo as a neurotoxic mechanism
associatedwith these pesticides.
Veronesi (211) identified the need for a
variety ofcell culture models and multi-
disciplinary end points to parallel neuro-
toxic targets in vivo. This can be difficult
because few specific targets of neurotoxic
action are known. To differentiate neuro-
toxicants from other chemicals, it was rec-
ommended that nonneural cells be
included in any battery to index basal-level
functioning. To accomplish this task a
tiered approach was proposed. The first tier
would include test systems to differentiate
neurotoxicants from cytotoxicants. Howev-
er, even this stage would require using
combinations ofnonspecific and specific
neural end points and batteries ofneural
and nonneural cell lines. The second tier
would differentiate classes of neuro-
toxicants (metals, cholinesterase inhibitors,
solvents, etc.) using specific end points that
are specifically targeted in vivo. This could
be difficult, given the variability of target
site relative to age and length ofexposure.
For example, at high doses, carbon disul-
fide is acutely toxic to the CNS whereas
lower doses and prolonged exposures pro-
duce a peripheral neuropathy. The third
tier would address distinct questions con-
fined to specific classes ofneurotoxicants
e.g., structure-activity relationships.
Preliminary evaluations of a similar
screening protocol have been published
(212). Using selected chemicals and a
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range ofsystems and simple end points, a
reasonable correlation between in vitro and
in vivo toxicity was seen. However, 2 of21
chemicals gave a false negative, and 4 posi-
tives gave an incorrect target cell type (astro-
cytes, not neurons). This result illustrates
both the potential uses and actual limita-
tions of in vitro systems as open-ended
screening systems.
Many of the in vitro experiments that
assess the toxicity ofvarious chemicals and
drugs demonstrate the difficulty of corre-
lating in vivo and in vitro effects ofneuro-
toxicants and the limitations ofan in vitro
model as an alternative approach for inves-
tigating complex effects at the level ofthe
nervous system. However, they present an
opportunity to use in vitro methodologies
for studying the underlying mechanisms of
action of toxicants. The information
obtained from such studies can be used in
the refinement of future studies in vivo.
The use ofcells in vitrohas resulted in new
insights into mechanisms potentially
important in our eventual understanding
ofthe mechanisms ofaction ofneurotoxi-
cants during both development and aging
of the nervous system and degenerative
brain disorders. Validation should include
analysis of the biomechanisms at work in
the model system and comparison with the
much more complex inner life ofthe tar-
get. Usually the scope of such a com-
parison is limited. Therefore, we are forced
to limit the validation process to a compar-
ison ofthe outcome ofthe model experi-
ments with the results of a comparable
challenge ofthe particular biological sys-
tem. Maintaining the requirements for
determining if a chemical is neurotoxic
with in vivo data from, the question
remains whether in vitro systems can be
developed that will be able to make the
same determination.
Conclusions
Current in vivo animal procedures are
sometimes less than ideal predictors of
human neurotoxicity. There is a consensus
that in vitro methods can provide useful
information concerning basic biological
processes underlying neurotoxicity and spe-
cific information concerning a chemical's
mechanism ofaction. At this stage ofmeth-
ods development and validation, in vitro
techniques can provide data that comple-
ment established in vivo testing approaches.
In vitro methods are not yet capable of
replacing in vivo tests because they do not
reflect in vivo nervous system complexity
nor assess the full range ofneurobiological
functioning in vivo, i.e., cognition, motor
coordination, and sensory processing and
integration. In vitro systems are not yet
viable means ofpredicting neurotoxicity
where the site of action is unclear or not
known. Results from in vitro studies must
be interpreted within the context of the
integrated nervous system. There is greater
confidence in chemically induced in vitro
changes if they can be associated with
specific neurotoxic effects in vivo.
It is important that procedures used in
in vitro neurotoxicology are valid. In this
context, test methods should both measure
what they are designed to measure, i.e.,
construct validity, and have the ability to
measure a characteristic relative to some
generally recognized standard, i.e., criterion
validity. The results of in vitro procedures
should also be interpretable within the con-
text ofplausible biological responsiveness to
toxicological exposure and possess the abil-
ity to predict neurotoxic risk in humans.
The process of demonstrating predictive
validity can be facilitated by selecting in
vitro end points associated with known
biological mechanisms of neurotoxic
effect. Therefore, attempts to validate in
vitro tests for neurotoxicity testing should
be limited to test systems designed for and
based on assessment of specific mecha-
nisms of neurotoxicity. The sole use of
open-ended general toxicity in vitro
screens of neurotoxicity at this time does
not seem warranted.
In vitro techniques have their greatest
potential in experiments involving mecha-
nistically based hypothesis testing. In vitro
approaches could be used in several target
sites where there is a significant under-
standing of basic biological processes
including chemically induced effects on
receptor-mediated changes, neurite out-
growth, electrophysiological changes, cer-
tain neurochemical end points (e.g.,
neuropathic esterase/acetylcholinesterase,
ion channel function), and alterations in
specific neurotransmitters, enzymes and/or
hormones. In vitro procedures may be par-
ticularly useful in assessing questions con-
cerning structure-activity relationships.
Other potential target sites for in vitro
examination include axonal transport,
blood-brain barrier, growth and develop-
ment, astrocytic-neuron interactions, bioac-
tivation, free radical/antioxidant systems,
xenobiotic metabolic capacity, and my-
elination. In each case, the choice ofthe cul-
ture preparations and complexity ofthe in
vitro system should be appropriate for the
hypothesis following additional methods
development and validation tested.
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